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ABSTRACT
Redundancy-aware learning of
protein structure-function relationships
by
Drew Bryant
The protein kinases are a large family of enzymes that play a fundamental role in prop-
agating signals within the cell. Because of the high degree of binding site similarity shared
among protein kinases, designing drug compounds with high specificity among the kinases
has proven difficult. However, computational approaches to comparing the 3-dimensional
geometry and physicochemical properties of key binding site residues, referred to here as
substructures, have been shown to be informative of inhibitor selectivity. This thesis intro-
duces two fundamental approaches for the comparative analysis of substructure similarity
and demonstrates the importance of each method on a variety of large protein structure
datasets for multiple biological applications.
The Family-wise Alignment of SubStructural Templates Framework (The FASST Frame-
work) provides an unsupervised learning approach for identifying substructure clusterings.
The substructure clusterings identified by FASST allow for the automatic evaluation of sub-
structure variability, the identification of distinct structural conformations and the selec-
tion of anomalous outlier structures within large structure datasets. These clusterings are
shown to be capable of identifying biologically meaningful structure trends among a di-
verse number of protein families. The FASST Live visualization and analysis platform pro-
vides multiple comparative analysis pipelines and allows the user to interactively explore
the substructure clusterings computed by The FASST Framework.
The Combinatorial Clustering Of Residue Position Subsets (CCORPS) method provides
a supervised learning approach for identifying structural features that are correlated with
a given set of annotation labels. The ability of CCORPS to identify structural features pre-
dictive of functional divergence among families of homologous enzymes is demonstrated
across 48 distinct protein families. The CCORPS method is further demonstrated to gener-
alize to the very difficult problem of predicting protein kinase inhibitor affinity. CCORPS is
demonstrated to make perfect or near-perfect predictions for the binding ability of 12 of the
38 kinase inhibitors studied, while only having overall poor predictive ability for 1 of the
38 compounds. Additionally, CCORPS is shown to identify shared structural features across
phylogenetically diverse groups of kinases that are correlated with binding affinity for par-
ticular inhibitors; such instances of structural similarity among phylogenetically diverse
kinases are also shown to not be rare among kinases. Finally, these function-specific struc-
tural features may serve as potential starting points for the development of highly specific
kinase inhibitors.
Importantly, both The FASST Framework and CCORPS implement a redundancy-aware
approach to dealing with structure overrepresentation that allows for the incorporation of
all available structure data. As shown in this thesis, surprising structural variability exists
even among structure datasets consisting of a single protein sequence. By incorporating
the full variety of structural conformations within the analysis, the methods presented here
provide a richer view of the variability of large protein structure datasets.
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proteins from distinct families of the kinome can be noted by the relatively
large percentage (73% overall across all inhibitors) of HPCs that span
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1Chapter 1
Introduction
1.1 Motivation
The disruption of signaling networks within the cell has been implicated in a wide vari-
ety of disease states [7, 8]. Many of the signal propagating agents within these networks
belong to a single, large family of enzymes—the protein kinases. Because of the highly
interconnected nature of the human kinase signaling network, even the dysregulation of a
single protein kinase, such as p38a , can lead to multiple pathological conditions. Specif-
ically, p38a dysregulation has been implicated in tumor formation, cell cycle disruption,
and inflammation disorders, such as rheumatoid arthritis and Alzheimer’s [8].
Because of the number of kinase-associated conditions, the protein kinases have come
to constitute 20-30% of the drug development programs at many companies [9]. However,
designing highly targeted kinase inhibitors has proven difficult for several reasons. Firstly,
the primary binding site targeted by approved kinase inhibitors, the ATP binding pocket,
happens to have considerable structural similarity across protein kinase domains [10, 11].
Secondly, because the protein kinases constitute the largest protein family encoded by the
2Figure 1.1 : Structural overrepresentation within the PDB. Log-log plot of the number
of available structures per non-redundant sequence cluster at 50% identity (NR50-clusters)
for the entire PDB. As shown above, the distribution of structures among NR50-clusters
within the PDB is highly non-uniform. Of the total 19975 NR50-clusters, 198 contain 100
or more structures while 4883 contain only a single structure.
human genome [9, 4], a large number of potential off-targets for any given kinase inhibitor
naturally exist. Therefore, the design of highly targeted kinase inhibitors necessitates the
comparative structural analysis of binding sites to identify differentiating structural features
[11].
Part of the difficulty in identifying differentiating structural features among large struc-
ture families, such as the protein kinases, is the difficulty of defining useful similarity mea-
sures that account for the structural features of importance. To quantify the functional
similarity of binding sites, local structural similarity has proven to be a highly informative
3proxy that is more directly quantifiable [12, 13, 14, 15]. For example, the 3-dimensional
position and physicochemical properties of binding site residues, such as the size of the
“gatekeeper” residue that mediates the availability of the kinase ATP binding site to in-
hibitors, have been shown to be highly informative of inhibitor binding specificity [10, 11].
Comparison of the key binding site residue positions (local structural features), rather than
the overall protein fold or topology (global structural features), has been demonstrated to
differentiate among the binding ability of different inhibitors [10, 11, 16].
A major obstacle for the development of local structure comparative methods is the
problem of structural overrepresentation in the Protein Data Bank (PDB) [17]. As shown
in Fig. 1.1, the distribution of protein structures in the PDB is highly non-uniform. Cur-
rently, 4883 protein sequences have only a single structure with  50% sequence iden-
tity and yet, at the same level of sequence identity, many sequences have over 100 avail-
able structures. Targets of pharmaceutical development, such as p38a , exhibit extreme
overrepresentation—p38a alone currently has 160 available structures. Because of the de-
gree of overrepresentation, identifying trends among datasets having a highly non-uniform
structure distribution across proteins becomes inherently difficult. Without accounting for
the overrepresentation, the trends identified will be largely trends among the most preva-
lent structures, representing only a fraction of the proteins of interest, rather than among
the unique proteins themselves.
A typical approach to dealing with overrepresentation is to construct sequence non-
redundant subsets of the original dataset and perform the analysis on now uniformly dis-
tributed structural data. However, as will be demonstrated throughout this thesis, the selec-
tion of a single structural representative for a given protein sequence is highly non-trivial
due to the fact that many proteins exhibit multiple structurally distinct conformations that
cannot be simultaneously captured by a single representative structure.
4Furthermore, as the number of available 3-dimensional protein structures in the PDB
continues to grow, as well as the frequency of overrepresentation, identifying meaningful
trends among the structures becomes increasingly difficult. Identifying structural trends,
specifically local structural trends, such as instances of binding site residue similarity,
has been shown to be highly predictive of the biological function of those binding sites
[18, 13, 15, 16]. The term substructure is used throughout this thesis to refer to such sets
of 3-dimensionally grouped residues that may or may not be sequence contiguous.
1.2 Contributions
This thesis introduces two fundamental approaches for the comparative analysis of sub-
structure similarity and demonstrates the importance of each method on a variety of large
protein structure datasets for several biological applications.
• The Family-wise Alignment of SubStructural Templates Framework (The FASST
Framework) provides an unsupervised learning approach for identifying substruc-
ture clusterings. The substructure clusterings identified by FASST allow for the au-
tomatic evaluation of substructure variability, the identification of distinct structural
conformations and the selection of anomalous outlier structures within large structure
datasets. The substructure clusterings identified by FASST both here and previously
[1] are demonstrated to be capable of identifying biologically meaningful structure
trends among a diverse number of protein families. Importantly, the implementation
of The FASST Framework provides a modular set of components that allow for the
quantification of local structure similarity between substructures to be easily cus-
tomized for different biological applications.
• The FASST Live visualization and analysis platform provides multiple comparative
5analysis pipelines and allows the user to interactively explore the substructure clus-
terings computed by The FASST Framework without the need to manually develop a
custom pipeline from The FASST Framework components.
• The Combinatorial Clustering Of Residue Position Subsets (CCORPS) method pro-
vides a supervised learning approach for identifying structural features that are cor-
related with a given set of annotation labels. No assumptions regarding the nature of
the annotation labels nor of the alignment type are made by CCORPS. The generality
of CCORPS allows for many different types of biological applications to be addressed
without requiring modification to the underlying algorithm. The ability of CCORPS
to identify structural features predictive of functional divergence among families of
homologous enzymes is demonstrated across 48 distinct protein families. The strong
performance of CCORPS across the families demonstrates the generality of the ap-
proach for protein families that vary greatly in the number of available structures, the
number of functional classes and the number of binding site residue positions.
• The CCORPS method is further demonstrated to generalize to the very difficult prob-
lem of predicting protein kinase inhibitor affinity. The protein kinase affinity exper-
iments presented in this thesis demonstrate the largest, both in number of structures
and number of inhibitors considered, structural analysis of the human kinome to date.
The predictive ability of CCORPS is compared to a recent state-of-the-art structure-
based approach and CCORPS is demonstrated to meet or exceed the capabilities of
previous methods. Specifically, CCORPS is demonstrated to make perfect or near-
perfect predictions for the binding ability of 12 of the 38 kinase inhibitors tested
in the inhibitor affinity dataset presented, while only having overall poor predictive
ability for 1 of the 38 compounds. Additionally, CCORPS is shown to identify shared
6structural features across phylogenetically diverse groups of kinases that are corre-
lated with binding affinity for particular inhibitors; such instances of structural sim-
ilarity among phylogenetically diverse kinases are also shown to not be rare among
kinases. These function-specific structural features may serve as potential starting
points for the development of highly specific kinase inhibitors.
Finally, both The FASST Framework and CCORPS implement a redundancy-aware ap-
proach to dealing with structure overrepresentation that allows for the incorporation of all
available structure data without requiring sequence non-redundant pre-filtering. As illus-
trated by The FASST Framework, surprising structural variability exists even among struc-
ture datasets consisting of only a single protein sequence and incorporating the full variety
of structural conformations within the analysis presented here provides a richer view of the
variability of protein structure datasets.
1.3 Thesis overview
First, important terminology and concepts that are referred to throughout the thesis, such as
the distinctions between unsupervised and supervised learning and the basis for structure-
function relationships are presented in Chapter 2. Chapter 3 introduces both The FASST
Framework and FASST Live and demonstrates the generalizability of the substructure clus-
tering approach to many different problem domains. Chapter 4 introduces the CCORPS
method itself, and Chapters 5 and 6 demonstrate the predictive ability of CCORPS for a
variety of large protein structure datasets.
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Background
In order to provide a minimal foundation for the remainder of the thesis, an overview of the
major distinctions between unsupervised and supervised learning is discussed here as well
as a brief introduction to structure-function relationships as they relate to protein enzymatic
sites [19].
2.1 The unsupervised learning problem
The problem of unsupervised learning pertains to identifying the underlying structure or
patterns that exist within an unlabeled dataset. Notable applications include ([20] pp.517–
518):
• Natural grouping identification (clustering)
• Novelty detection
• Outlier and anomaly detection
• Trend identification
8• Compression (data reduction)
• Data uniformity assessment
In particular, the work presented in this thesis will make use data clustering throughout
to better understand the natural similarity groups that occur among 3-dimensional protein
structures.
Ideally, items falling within the same cluster should have smaller distances to one an-
other than to items in other clusters. Therefore, a precise definition of item-item distance
is necessary in order to quantify the quality of a cluster. In fact, the notion of a cluster is
so intertwined with a specific definition of the item-item distance that completely different
clusterings can be obtained by simply altering the distance function.
Take, for example, a bag containing spheres having small, medium and large sizes that
are colored either red, green or blue. Assume that at least one of each color exists for
each size. Given distance measures dcolor(x,y)= {0 if color(x) = color(y), 1 otherwise} and
dsize(x,y) = {0 if size(x) = size(y), 1 otherwise}. Applying an agglomerative hierarchical
clustering method ([20] pp.552–553) and stopping at the level of 3 clusters while using
dcolor will result in color-homogeneous clusters, but within each cluster will be a mixture
of all sizes. Repeating the clustering using dsize instead will result in size-homogeneous
clusters, each containing a mixture of all colors. Finally, repeating the clustering again
using dboth = dcolor+dsize and stopping at 9 clusters would result in clusters homogeneous
in both size and color.
2.2 The supervised learning problem
The problem of supervised learning is distinguished from unsupervised learning by the
addition of a set of labels to the data points. The addition of labels allows supervised
9approaches to identify trends or groupings within the data that correlate with the given set
of labels. Most applications of supervised learning involve using a labeled training set to
learn a set of rules that can then be applied to predict the labels for novel, unlabeled data
([20] pp.16–17).
For example, the problem of spam detection is easily cast as a supervised learning prob-
lem. Given a set of emails (data points) that have been labeled as either spam or not-spam
(labels), train a classifier to learn the features of the emails (e.g., email length, prevalence
of CAPITILIZATION, number of misspelled words). Then, given a new (unlabeled) email
message, the classifier applies the learned decision rules to predict the label for the new
email—spam or not-spam.
2.3 Structure-function relationships
The function of a protein is intimately linked to its 3-dimensional structure [14, 21]. Specif-
ically, the 3-dimensionally grouped residues (amino acids) that make up the binding sites
of enzymatic proteins have been shown in several instances to dictate function alone [22].
That is, given two proteins without discernible sequence or fold similarity, substructure
approaches have been shown capable of identifying local instances of structural similarity
indicative of functional similarity [23]. The term substructure is used throughout this thesis
to refer to such sets of 3-dimensionally grouped residues that may or may not be sequence
contiguous.
For example, the Ser-His-Asp catalytic triad of the serine proteases is a well-understood
example of function-determining substructure that appears to have been convergently evolved
in both bacterial and mammalian species. The 3-dimensional geometry of the triad is shared
among both lineages despite the absence of both sequence and topological similarity.
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Because of the strong relationship between the 3-dimensional structure and function of
proteins, repositories such as the Structure-Function Linkage Datbase (SFLD) [24] have
been developed to provide curated annotations. For example, the Enolase Superfamily (ES)
is currently known to include 20 different enzymatic protein families that share a common
partial reaction. The shared partial reaction is performed using a common set of active site
residues in each family and has been heavily conserved throughout the course of evolution
in spite of specialization of the remainder of the binding site. For example, one member
of the ES is depicted in Fig. 2.1 and the 5-residue catalytic substructure that has been
conserved throughout the ES is shown.
The Enzyme Commission (EC) class annotation [25] for a given enzyme provides a
hierarchical classification of the type of reaction catalyzed by the enzyme as well as the
type of substrate molecule on which the enzyme operates. In the 4-tiered EC classification
A.B.C.D, where each level is delimited by a period (.), the values for A through D increase
in annotation specificity. For example, the structure of mandelate racemase (Fig. 2.1) has
been annotated to have the EC class 5.1.2.2. The definitions for each of the 4 tiers is:
EC Number Definition
5.-.-.- isomerase
5.1.-.- racemase or epimerase
5.1.2.- acting on hydroxy acids and derivatives
5.1.2.2 mandelate racemase
where isomerase is the least specific functional annotation and the mandelate racemase
annotation is the most specific, providing both the reaction catalyzed and the preferred
substrate molecule of the enzyme.
The functional diversification of the ES can be examined by comparing the EC class
annotations of the proteins known to be ES members. A subset of the reactions catalyzed
11
Figure 2.1 : Mandelate racemase active site. The structure of an ES member active site
(mandelate racemase) is shown above. The residue positions conserved across members of
the ES are shown in blue stick representation and a ligand is shown in red surface represen-
tation; a metal ion is shown as the green sphere.
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by members of the ES [3] include:
EC Number Family
4.2.1.11 enolase
4.2.1.40 glucarate dehydratase (GlucD)
4.2.1.113 o-succinylbenzoate synthase (OSBS)
4.3.1.2 methylaspartate ammonia lyase (MAL)
5.1.2.2 mandelate racemase (MR)
5.5.1.1 muconate lactonizing enzyme (MLE)
As shown above, the ES contains families of enzymes with highly similar enzymatic func-
tions (e.g., 4.2.1.11 and 4.2.1.40) and families that differ in function at all 4 tiers of the
EC classification (e.g., 4.2.1.11 and 5.1.2.2). Because EC numbers provide an estab-
lished set of protein function classification labels, they are used throughout this thesis as a
convenient means of assigning proteins to discrete classes. In Ch. 5, EC classes are used to
define the set of proteins constituting a single family of functionally related enzymes.
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Chapter 3
An Unsupervised Learning Approach: The
FASST Framework
3.1 Motivation
As the amount of available protein structure data continues to increase, identifying bio-
logically meaningful structural trends becomes increasingly difficult using conventional
approaches such as structure superposition and pairwise structure comparison. Identify-
ing the impact that structural variation has upon the function of related protein structures
is becoming increasingly important for understanding the structural basis for functional
diversification [26].
For instance comparative structural analysis of ligand binding sites both within and
across species has played a significant role in the evaluation of lead compounds as well as
finding new targets for existing compounds [18, 27, 28] For rigid docking methods, identi-
fying the number of specific structure conformations to test so that the structural variation
of the target is sufficiently represented has a significant impact on the success of these meth-
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ods [29]. However, identifying the minimum number of unique structural conformations
for a protein requires the adoption of comparative structure analysis approaches capable of
considering all available structure data simultaneously.
Approaches for cataloging and classifying structures at the domain level, such as Pfam [30],
CATH [31] and the CDD [32], have been heavily developed over recent decades and have
become critical resources for understanding the structural landscape of the proteome. How-
ever, local structure comparison can provide unique insights into the evolution and function
of proteins that are inaccessible to fold- and sequence-based analysis approaches [33, 34].
In order to facilitate the use of comparative local structure analysis, The FASST Frame-
work was developed to provide a general framework for the local structure analysis of large
protein datasets in a wide variety of application domains. The approach used by The FASST
Framework to allow for easy modification and customization to different types of structure
analysis is detailed here.
3.2 Problem statement
The unsupervised learning problem that The FASST Framework supports can be succinctly
stated as follows:
Given a set of protein substructures, identify the unique structural conforma-
tions present.
To implement this analysis, The FASST Framework provides the following interface:
• Input: aligned set of protein substructures
• Output: a substructure clustering
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In the definition above, a set of r residues from a single protein structure constitutes
one substructure. In order for a set of n input substructures to be considered “aligned”, a
residue-residue bijection among all pairs of the n substructures must exist. This pairwise
residue-residue bijection defines a one-to-one correspondence between the r residues of
substructures A and B, for all pairs of the n substructures.
Many approaches could be taken to generate a set of aligned substructures for input
to The FASST Framework. For example, in Sec. 3.11.1, the same 4-residue substructure
(Glu71, Leu75, Asp168, Phe169) is compared across all available structures for p38a .
There, the substructure alignment is trivial because the same 4 residues are compared across
different structures of the same protein; that is, Glu71 in structure A corresponds to the same
Glu71 in structure B, and likewise for the remaining residue positions.
Another approach to generating an aligned substructure set, depicted in Sec. 3.11.2,
is to use the alignment columns of a multiple sequence alignment in order to determine
the residue-residue correspondence across all proteins in the sequence alignment. This
approach is used throughout this thesis. Additional alignment approaches are enumerated
in Sec. 3.5.
The substructure clustering output by FASST can be used to identify a number of traits
for the input substructure set. As demonstrated in Sec.3.11.1, the substructure clustering
can be used to identify the number of distinct structure conformations for the residues of the
substructures. Outlier substructures can also be distinguished in the example in Sec. 3.11.1
by identifying substructures that are distant from all of the major clusters.
The generality of the method implemented by The FASST Framework was achieved by
minimizing the number of assumptions made concerning the nature of the input substruc-
tures (i.e., no particular alignment method is assumed) and allowing the major components
of The FASST Framework to be independently modified or replaced entirely while still re-
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taining the functionality of the remainder of the components (see Sec. 3.10.1 for example
usage).
3.3 Related work
Seminal work by Holm et al. 1996 [35] on mapping the protein structure universe demon-
strated how an all-against-all (global) structure comparison could reveal the high-level rela-
tionships among protein structure folds. A number of approaches to comparative structure
and binding site analysis have also been developed and demonstrated to successfully iden-
tify biologically meaningful trends. Previous work illustrated by Kinjo et al. 2009 using
a surface similarity network approach [36] identified a high-level organization of protein
ligand binding site similarity among structures spanning the entirety of the (ligated) PDB.
The recently developed Protein Surface Classification (PSC) method illustrated an approach
similar to that Kinjo et al. by clustering protein binding site surfaces. Due to the diversifi-
cation of enzymatic function within divergently related families that share a common fold
but exhibit a range of enzymatic activity (such as the ES), the goal of PSC is the functional
annotation of protein sequences by providing a finer classification than domain ontologies
such as CATH [31] and SCOP [37].
Approaches to efficiently searching large structure datasets for local structure similarity
to a query binding site have been thoroughly investigated [38, 39, 40, 41, 42, 43, 44, 45,
46, 2]. A major distinguishing factor among these local structure search and comparison
methods is the approach used to quantify local structure dissimilarity. However, given the
structural variety of protein functional sites, it is difficult to derive a single measure capable
of optimally quantifying meaningful similarity/dissimilarity of local structural features in
every possible context. For example, while the electrostatic surface potential comparison
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approach implemented by HTHQuery [43] is capable of identifying specific DNA binding
site motifs with high specificity, the same dissimilarity measure may not be appropriate for
distinguishing among binding sites that interact primarily through steric and hydrophobic
interactions.
Additionally, the problem of aligning proteins via sequence, structure or a combination
thereof has been studied for many decades, producing a variety of both general and highly
specialized techniques. General global structure alignment methods such as DaliLite [47],
CATHEDRAL [48], CE [49], VAST [50], HOMSTRAD [51] and MATT [5] have proven capable
of recognizing fold similarity among highly divergent protein sequences. Sequence-based
approaches include HMMER [52], PROSITE [53], CLUSTALW [54] and MUSCLE [55], to
name a few. Local structure alignment approaches, such as those used for local search
and comparison discussed in the previous paragraph provide an additional approach to
identifying corresponding features among proteins in cases where global structure- and
sequence-based are incapable [33, 34].
By providing a general framework within which to relate alignment methods with local
structural comparison methods mentioned above, The FASST Framework provides a uni-
fied approach to combining these approaches to facilitate the large-scale analysis of local
structural features as detailed below.
3.4 Method overview
Given the sheer quantity and variety of both alignment and comparison methods that have
been developed for both general and highly specific biological applications, The FASST
Framework was designed to be agnostic to both the alignment and dissimilarity measure
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set of proteins being studied.
cluster identification
substructure clustering
aligned substructures
FASST Framework
dissimilarity measurement
feature selection
dimensionality reduction
In order to compute substructure clusterings, FASST first
computes the pairwise dissimilarity measure among pairs of
the aligned substructures. Next, one feature vector per sub-
structure is constructed from the pairwise comparisons of that
substructure with the other aligned substructures. Because the
feature vectors representing each substructure are typically
of very high dimension, dimensionality reduction is used to
compute a low-dimensional approximation of each vector.
Finally, the dimensionality reduced feature vectors are clus-
tered into sub-groups. Each of these steps is detailed in sec-
tions 3.6-3.9.
3.4.1 Interpreting clustered substructures
In order to build intuition for interpreting the substructure clusterings computed by The
FASST Framework, a set of aligned substructures with the corresponding clustering is
shown in Fig. 3.1. In this case, the comparison set is a collection of 5-residue enzymatic site
substructures, 83 sites in all, that were aligned by LabelHash [2] as previously described in
[1].
Each point in the scatter plot (Fig. 3.1(b)) is a feature vector that represents a single
substructure. The feature vectors are colored by their cluster assignment as determined by
FASST. The colored marker labels are present only to illustrate a single example PDB ID
for one of the protein substructures in each cluster.
If substructure A is nearby substructure B in the clustering, then these two substruc-
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Figure 3.1 : Substructure clustering. A set of aligned substructures (a) and the corre-
sponding substructure clustering (b) as computed by FASST is shown above. As can be
seen, 4 clusters have been identified and are denoted by color. Each 5-residue substructure
in (a) corresponds to a single point (feature vector) in (b). Adapted from [1].
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tures are similar, with respect to the dissimilarity measure used, relative to the remaining
substructures in the comparison set. Conversely, two substructures that are far apart in the
visualization are dissimilar.
In the structural alignment shown in Fig. 3.1(a), all 83 substructures are shown. Each
is colored according the cluster assignment identified by FASST. Note that substructures
with the same color are well-aligned with one another and are distinguishable from the
substructures of a different color. The gold-colored outlier (labeled 1BGP in scatter plot)
corresponds to the gold-colored outlier in the full substructure alignment.
3.5 Defining aligned substructures
Because the choice of an alignment approach can be specific to the type, quantity and size
of the substructures being analyzed, the generalized The FASST Framework introduced
here provides a general approach that is alignment agnostic.
In particular, The FASST Framework has previously been combined with several differ-
ent alignment approaches:
• Local structure-based alignment (LabelHash)
• Global structure-based alignment (CE)
• Progressive sequence-based alignment (CLUSTALW)
• Profile-HMM sequence-based alignment (HMMER)
Choice of an alignment approach depends on many factors including:
• Degree of sequence conservation
• Fold similarity
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• Function of the selected residues (e.g., binding site)
The results presented in this chapter all utilize the HMMER-based alignments provided
by Pfam (version 25.0) [30].
3.6 Computing pairwise substructure dissimilarities
The ability to identify functionally similar features among proteins depends directly upon
the dissimilarity measure used for quantifying the similarity of a pair of proteins. As a case
study in how a dissimilarity measure can drastically effect the ability of computational
approaches to identify functional similarity, the proteins of the ES are examined here again.
As can be seen in Fig. 3.2(a), ES structures have higher Ca RMSD variability than side
chain RMSD variability when examining the 5-residue active site substructure shown in
Fig. 3.2. As shown in Fig. 3.2(b)-(c), Ca RMSD is not as effective as side chain RMSD in
distinguishing ES structures from non-ES structures.
Because side chain positions of the ES motif are more heavily conserved than the Ca
positions, side chain RMSD was shown to be a more powerful similarity measure for iden-
tifying substructures that share the same ES partial reaction step [2]. However, in cases
where side chain positions are less constrained and therefore tend to have a higher variance
(e.g., flexible loop regions, protein-protein interfaces), dissimilarity measures other than
side chain RMSD may be more appropriate.
In order to facilitate the wide-applicability of The FASST Framework to many different
types of substructure analysis, The FASST Framework is not constrained to using any par-
ticular dissimilarity measure. As detailed in Sec. 3.6, many different dissimilarity measures
can be freely substituted to suit the particular application.
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3.6.1 Pairwise dissimilarity measures
Several alternative approaches to computing the structural similarity of pair of substruc-
tures are examined and compared here to build intuition for how the choice of a dissimilar-
ity measure for a particular problem will affect the resulting feature vectors computed by
The FASST Framework. As shown in Fig. 3.3, The FASST Framework was used to com-
pute feature vectors for all structures of the PFAM:PKINASE family using pairwise com-
parisons with several different dissimilarity measures. The structure shown in Fig. 3.3(e)
corresponds to a p38 kinase structure with bound imatinib molecule (PDB:3HEC); the 5-
residue substructure shown corresponds to the C-helix (E71, L75), gatekeeper (D106) and
the DFG-motif (D168, F169) residues. The feature vectors computed by The FASST Frame-
work using Ca RMSD, side chain RMSD, BLOSUM-RMSD and TRAIT-RMSD are shown in
Fig. 3.3(a) through (d), respectively. The procedure for calculating each of these dissimi-
larity measures is detailed in the following sections.
Figure 3.2 (preceding page): Effect of dissimilarity measure on identification of eno-
lase superfamily members The ability of LabelHash [2] to distinguish proteins in the ES
from non-ES structures is greatly dependent upon the dissimilarity measure used for scor-
ing structural similarity during the structure search. The substructure responsible for the
conserved partial reaction among members of the ES consists of the 5 residues from which
the ES motif used here is derived [3]. This 5-residue substructure is shown in (a) for 7 dif-
ferent ES members. One of the 5 residues is highlighted to illustrate the deviations among
the Ca and side chain centroid positions that are marked with dark and light gray circles,
respectively. In the case of ES member proteins, the Ca positions have greater variabil-
ity than the side chain positions. In (b) and (c), the structure matches identified using side
chain centroid and Ca RMSD, respectively, are compared. The x-axis in each plot above de-
notes the RMSD of the ES motif to identified matches and the y-axis denotes the normalized
number of structures that matched the motif at a particular RMSD. Dark gray and light gray
denote matches to ES and non-ES structures, respectively. The dashed lined corresponds
to the LRMSD distance threshold for matches having statistically significant similarity as
identified by the LabelHash statistical model. As can be seen above, side chain RMSD
clearly distinguishes ES and non-ES structures while Ca RMSD does not.
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Figure 3.3 : Effect of dissimilarity measure on the feature vectors computed by The
FASST Framework . (a) Ca RMSD, (b) side chain RMSD, (c) BLOSUM-RMSD, (d) TRAIT-
RMSD, (e) the 5-residue kinase substructure being compared among structures of the
PFAM:PKINASE family in (a) through (d) above. Comparison of the feature vectors be-
tween (a) and (b) above illustrates that side chain RMSD is more variable than Ca RMSD
among the PFAM:PKINASE family. The combination of side chain RMSD with a side chain
residue dissimilarity measure has a more subtle affect on the feature vector distribution as
shown by comparing (b) to (c) and (d) above.
25
Geometry-only dissimilarity measures
The Root Mean Square Deviation (RMSD) between a pair of aligned protein structures is
one frequently used measure of structural similarity and is calculated as:
RMSD =
s
m
Â
i=1
Dx2+Dy2+Dz2
m
(3.1)
for a set of m aligned points. In the case of Ca RMSD, the aligned points are the Ca atoms
of each residue. As discussed in Sec. 3.5, both global and local approaches to calculating
pairwise alignments exist, such as CE (global) or LabelHash (local), and Ca RMSD can be
used to quantify the similarity of a pairwise alignment in both cases. For side chain RMSD,
the aligned points are instead the coordinates of the side chain centroids for each residue.
Geometry-augmented dissimilarity measures
Geometry-only dissimilarity measures, such as Ca RMSD, will score a pair of substruc-
tures having highly similar backbone geometry as being very similar, regardless of possi-
ble mutations or residue substitutions that may be present in one of the substructures. For
applications where local fold similarity is the quantity of interest, disregarding residue sub-
stitutions and only considering backbone geometry may be appropriate. However, when
comparing the binding site substructures among a homologous family of proteins, such as
the protein kinases, that share a large degree of fold similarity within the binding site re-
gion, geometry-only dissimilarity measures such as Ca RMSD may have very little variance
and fail to capture the important substitutions of functionally important residue positions.
A simple approach to incorporate residue substitution penalties into a geometric dis-
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similarity measure is to simply sum the respective dissimilarity measures:
d = dside chain centroid+dresidue substitution (3.2)
Given the above approach for combining a geometric and residue substitution penalty, it is
still necessary to define how residue substitution is quantified between a pair of substruc-
tures, where each substructure is composed of multiple residues.
Canonical residue substitution matrices, such as BLOSUM62 [56] or PAM120 [57], that
are frequently used during sequence alignment, provide a well-understood basis for quan-
tifying the likelihood of a residue substitution at a particular sequence position. These
substitution matrices are typically provided as a 20⇥ 20 matrix that defines the penalty
for substituting any residue A for any other residue B. The major distinction between the
different types of substitution matrices is the algorithm used for computing the likelihood
of each substitution.
The following procedure was used to convert the canonical residue substitution ma-
trices that are typically represented as a matrix of residue-residue scores with larger val-
ues indicating more likely substitutions. Given matrix M having similarity score values
si, j 2 [min(M),max(M)], the following residue-residue dissimilarity matrix is created:
M0 =
 M+max(M)
max(M) min(M) (3.3)
The resulting dissimilarity matrixM0 contains elements di, j 2 [0,1] with larger values indi-
cating greater dissimilarity. The dissimilarity of a pair of substructures, each containing m
residues, is then calculated as:
dresidue substitution(s1,s2) =
Âmi=1M0[si1,si2]
m
(3.4)
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where M0[i, j] is the dissimilarity of residues i and j as calculated above and si1 is the ith
residue of substructure s1.
An alternative approach to measuring residue-residue similarity that has been demon-
strated to be effective for identifying functional similarity among small molecule binding
sites of the protein kinases is the pharmacophore trait measure introduced by [58]. The
dissimilarity between a pair of substructures is quantified by a combination of chemical
feature traits, such as aliphaticity, number of hydrogen bond donors and acceptors, aro-
maticity and hydrophobicity. Combining the dissimilarity scores for each of these traits
with a geometric dissimilarity measure, such as side chain RMSD, yields the following:
d(s1,s2) = dside chain centroid(s1,s2)+dsize(s1,s2) +
daliphaticity(s1,s2)+daromaticity(s1,s2) +
dhydrophobicity(s1,s2)+dhbond acceptor(s1,s2) +
dhbond donor(s1,s2).
This dissimilarity measure is referred to hereafter as the TRAIT-RMSD and is used through-
out Ch. 4–6 for all pairwise binding site substructure comparisons.
3.6.2 Comparison of dissimilarity measures
As shown in Fig. 3.3, the biggest affect on the feature vectors computed by The FASST
Framework in the case of the protein kinase substructure shown in Fig. 3.3(e) comes from
using side chain RMSD rather than Ca RMSD. This result is not particularly surprising
considering the backbone positions of the residues in (e) are more constrained than the side
chain positions. The addition of the residue substitution dissimilarity measure as shown
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in (c) and (d) has a much less dramatic effect on the number of identifiable feature vector
clusters.
3.7 Computing feature vectors
In order to compute the per-substructure feature vectors for a set of substructures, FASST
computes a dissimilarity matrix for the substructures. Given n substructures, the full all-
vs-all dissimilarity matrix would be comprised of n(n 1)/2 unique comparisons (due to
dissimilarity measure symmetry). Cell (i, j) within the dissimilarity matrix corresponds
to d(si,s j) where d is the dissimilarity function described in the Section 3.6 and si and s j
are both protein substructures. Each row of the dissimilarity matrix is considered a feature
vector, where row i of the dissimilarity matrix is a feature vector representing the structural
dissimilarities of substructure si to the remainder of the substructures in the matrix.
However, due to the fact that the dissimilarity matrix computation grows as O(n2) with
the number of substructures analyzed, the feature vector computation step can become
prohibitively expensive to compute for very large numbers (>1000) of substructures. To
address this issue, two approaches to approximating the full dissimilarity matrix while only
computing a fraction of the O(n2) comparisons are introduced below.
3.7.1 Randomized landmark selection
The most computationally expensive step of FASST is the calculation of the n⇥n dissimi-
larity matrix. Because the clustering step requires only the dimensionality-reduced form of
the feature vectors, it is not strictly necessary to compute the full n⇥n dissimilarity matrix.
Because of the large degree of structural overrepresentation for many proteins, it is pos-
sible to randomly sample a subset of the dissimilarity matrix columns and then apply the
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Figure 3.4 : Dimensionality reduced feature vectors computed from the full n⇥n dis-
similarity matrix. The feature vectors computed from the full n⇥ n dissimilarity matrix,
for the 5-residue substructure shown in Fig. 3.3(e), across all of the PFAM:PKINASE family
proteins, are shown above.
same dimensionality reduction and clustering steps (Section 3.8 and 3.9) while preserving
the same cluster membership. This is in fact a common technique in dimensionality reduc-
tion [59]. By randomly sampling columns from the dissimilarity matrix, the computation
is reduced from O(n2) to O(kn) where k⌧ n typically, allowing The FASST Framework to
scale easily as additional structures become available.
The columns of the dissimilarity matrix that will be sampled are referred to hereafter
as “landmarks.” While dimensionality reduction is detailed in the following Sec. 3.8, it is
important to mention that the comparisons made here in assessing the landmark selection
approaches are based upon comparing the dimensionality reduced versions of the feature
vectors, which for consistency have been arbitrarily made to be 2-dimensional.
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Figure 3.5 : Dimensionality reduced feature vectors computed from a k⇥ n dissim-
ilarity matrix subset. The feature vectors computed from a k⇥ n subset of the full
n⇥ n dissimilarity matrix for the 5-residue substructure shown in Fig. 3.3(e), across
all PFAM:PKINASE family proteins, are shown above. The two different approaches
to landmark sampling, uniform random and non-redundant random, are compared for
k 2 {2,5,10,20,50}. As can be seen above, the k-random NR approach produces a cluster-
ing very near that of the full dissimilarity matrix (compare to Fig. 3.4) by k= 5, as opposed
to k = 20 for the uniform random approach.
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The simplest landmark sampling approach is to select k landmarks uniformly at ran-
dom. Given this approach, the value selected for k should ideally be as small as possible
to sufficiently approximate the feature vectors of the full dissimilarity matrix (after dimen-
sionality reduction). The feature vectors computed using k uniformly random landmarks
for k 2 {2,5,10,20,50} are shown in Fig. 3.5 and can be compared with the feature vectors
for the full dissimilarity matrix shown in Fig. 3.4. For k 2 {20,50}, the resulting feature
vectors shown in Fig. 3.5 are a close approximation of the full feature vectors. However,
for k 2 {2,5,10} significant deviations are apparent.
Because the landmarks selection is non-deterministic, repeated trials will select differ-
ent sets of landmarks. By repeating the feature vector computation with many different
random landmark selections while keeping k constant, it was noted that some random se-
lections produced very close approximations even at the k = 5 level, but the variance in
quality was found to be high. Because the feature vector computation step is critical to
the following cluster identification step, a value for k that was able to reliably reproduce
a close approximation of the full dissimilarity matrix is necessary. Further inspection of
the landmarks selected in the degenerate cases revealed that the primary cause of the high
approximation variance was the extreme overrepresentation of a small number of protein
sequences. These overrepresented sequences were sampled multiple times in the degener-
ate cases, causing a low amount of diversity among the selected landmarks.
3.7.2 Redundancy-aware landmark selection
In order to address the problem of structurally overrepresented sequences during landmark
selection an alternative redundancy-aware approach was developed. By sampling from a
non-redundant subset of the protein sequences present among the substructures, the worst-
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case behavior of the uniform random selection where all landmarks correspond to a single
protein sequence can be avoided completely.
The redundancy-aware landmark sampling approach implemented first partitions a pro-
tein family into sequence non-redundant groups at the 50% sequence identity level (NR50-
clusters). Then, the highest resolution structure from k randomly selected non-redundant
groups is selected as a landmark. For a set of substructures having fewer than k NR50-
clusters, each of the NR50-clusters will contribute one representative structure, resulting in
|NR50-clusters | landmarks.
As shown in Fig. 3.5 for k2 {2,5,10,20,50}, randomly selecting k landmarks from dis-
tinct NR50-clusters results in feature vectors that closely approximate the full dissimilarity
matrix for smaller values of k when compared to the uniform random selection procedure.
To be conservative, k = 20 for the redundancy-aware landmarks selection procedure was
selected as the default method for The FASST Framework. Note that while randomized
landmark selection will inherently select a different random set of landmarks on repeated
executions, the process can be made repeatable by seeding the random number generation
process with a constant value across trials.
3.8 Dimensionality reduction
In order to reduce the dimensionality of the computed feature vectors, Principal Compo-
nents Analysis (PCA) [60] is used to transform the raw vectors of the computed dissimilarity
matrix (or matrix subset) into a lower dimensional embedding. Only the first two princi-
pal components are kept by default and the remainder of the components are truncated,
thereby resulting in a 2-dimensional feature vector representation of each of the n protein
structures in the dataset (i.e., an n⇥ 2 sub-matrix of the transformed vectors). Previous
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work [1] demonstrated that the amount of data variance present in the identified principal
components dropped sharply after the first 2 components.
However, a significant structural redundancy problem arises when performing the di-
mensionality reduction of the feature vectors. By default, PCA weights the importance of
all feature vectors equally when computing the low-dimensional embedding that optimally
preserves the variance of the original data. Overrepresented protein sequences cause PCA
to place unequal emphasis on preserving the variance among structures for the overrepre-
sented sequence rather than equitably across all of the sequences in the dataset. This bias
in the embedding effectively hides variation among distinct protein sequences in favor of
preserving the variation among the overrepresented sequence.
To remove overrepresentation bias, PCA is first computed with a non-redundant subset
of the rows of the dissimilarity matrix; that is, one feature vector is computed for each
NR50-clusters. Then PCA is computed for this sequence non-redundant set of feature vec-
tors alone, thereby avoiding the bias induced by structurally overrepresented sequences.
Next, the feature vectors are computed for all structures in the dataset and then transformed
to a lower dimensional embedding using the PCA transformation matrix computed from
the non-redundant subset of the dataset. This approach amounts to computing a binary
weighted PCA where all feature vectors have a weight of 0 with the exception of the non-
redundant subset of structures that have a weight of 1.
3.9 Clustering feature vectors
Given the dimensionality reduced feature vector representation of the substructures, these
vectors are then clustered to identify sub-groups that share strong structural similarity.
However, the number of clusters to expect is difficult to quantify beforehand and has been
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noted in previous work [1] to vary greatly depending on particular substructure being ana-
lyzed.
The Gaussian Mixture Model (GMM) clustering method as implemented in the MCLUST
package [61] is able to identify both the number of clusters present and the cluster mem-
berships for each of the feature vectors. The GMM approach was demonstrated in previous
work [1] to identify clusterings that corresponded to biological properties such as ligation
state and fold class.
However, a single-pass GMM clustering approach is not sufficient to identify the num-
ber of clusters present. The approach implemented by MCLUST is to iteratively increase the
number of multivariate Gaussian distributions present in the mixture model and then eval-
uate the fitness of a particular k-Gaussian model using the Bayesian Information Criterion
(BIC). Because BIC is a regularized approach, given 2 models with equally good fit to the
feature vectors, the model having fewer Gaussians is preferred (assuming an equal number
of covariance matrix parameters per Gaussian are allowed for both models).
3.10 Design and implementation of The FASST Framework
To facilitate the application of The FASST Framework to a wide variety of structural com-
parison problems, the framework is designed to have a highly modular architecture with
components having only a minimal interface to facilitate reuse and ease of customization.
An overview of the components making up The FASST Framework is shown in Fig. 3.6
3.10.1 Components
As shown in Fig. 3.6, The FASST Framework is composed of 5 major types of components
that each expose only a minimal interface with one another. The components can in fact
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Figure 3.6 : Design of The FASST Framework The FASST Framework provides a mod-
ular architecture within which components, such as dissimilarity measures can be easily
swapped and modified without requiring modifications to other components. A sampling
of interchangeable dissimilarity measures and feature vector computation procedures are
shown within solid rectangles.
be thought of as a loosely associated set of data transformations that have the specific
interfaces described below.
Dissimilarity measures
All dissimilarity measures are assumed to be pairwise comparisons having the function
signature: d(s1,s2) and return a floating point value x  0.
Feature vector computations
A feature vector computation has the function signature: f (S,d) and returns an length-n
array of m-dimensional vectors, where S is a set of n substructures and d is a dissimilarity
measure. The resulting n⇥m feature vector matrix is labeled V hereafter.
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Dimensionality reducers
A dimensionality reducer has the function signature: r(V) and returns a new n⇥m0 set of
feature vectors V0, such that m0  m.
Clusterers
A clusterer has the function signature: c(V0) and returns a length-n array of integers indi-
cating the cluster ID assigned to each of the n substructures.
All of the variants of each component type discussed above reside in separate modules
and have been implemented in the Python programming language. An example of how
to construct a custom analysis pipeline using components from The FASST Framework is
demonstrated in Listing 1.
1 # select components to use
2 from fasst.featurevecs import compute_features
3 from fasst.distances import calpha_lrmsd
4 from fasst.dimreducers import pca_reduce
5 from fasst.clusterers import gmm_cluster
6 # define the set of substructures to analyze
7 substructures = [s1, s2, ..., sN]
8 # compute the feature vectors
9 feature_vectors = compute_features(substructures, calpha_lrmsd)
10 # reduce the dimensionality
11 dimreduced_feature_vectors = pca_reduce(feature_vectors)
12 # cluster the feature vectors
13 clustering = gmm_cluster(dimreduced_feature_vectors)
Listing 1: An example Python session demonstrating how components from The FASST
Framework can be combined to construct an application-specific implementation.
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In the example shown in Listing 1, a set of substructures that have been fully defined
by the user are paired with the calpha lrmsd dissimilarity measure and used to compute
a set of feature vectors. The dimensionality of the vectors is next reduced by applying the
pca reduce transform. Finally, the clustering of the original substructures is determined
by applying the gmm cluster to the dimensionality-reduced feature vectors.
3.11 Interactive visualization and analysis with FASST Live
FASST Live builds on top of The FASST Framework by providing multiple automated ap-
proaches to generating a set of substructures to analyze and providing a web-based visu-
alization and exploration interface to the resulting clustering. Each of the pipelines imple-
mented by FASST Live provides a different form of analysis by modifying how the sub-
structures are generated from the user query and are explained in detail below. In addition
to the automated pipelines the user can submit a pre-computed substructure alignment to
allow greater flexibility and facilitate the application of The FASST Framework to a wide
variety of alignment approaches.
3.11.1 Single-sequence, multi-structure pipeline
As illustrated in Fig. 1.1, many protein sequences within the PDB contain a multitude of
available structures. For example, at the time of this writing p38 alone has 160 available
crystallographic structures in the PDB which have been derived under different crystalliza-
tion conditions, mutations and bound ligands. In order to explore the structural variety
present among all available p38 structures (or any other sequence of interest), FASST Live
provides a single-sequence, multi-structure pipeline.
As an example, the single-sequence, multi-structure feature vectors computed for a 4-
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Figure 3.7 : FASST Live Each of the pipelines within FASST Live implements a different
approach to gathering substructures for analysis with The FASST Framework. Additionally
FASST Live provides a rich graphical visualization of the clustered substructures that allows
the user to explore high-level structural trends at multiple levels of detail.
residue p38 substructure (residues 71, 75 (C-helix), 168 and 169 (DFG motif)) is shown
in Fig. 3.8. The set of substructures compared is obtained by automatically selecting all
protein structures in the PDB that have the same UniProtKB sequence ID as the reference
substructure (PDB:3HEC). An annotated screenshot of the interactive FASST Live visual-
ization is shown also in Fig. 3.8.
Immediately upon examination of the feature vectors in Fig. 3.8 it is apparent that 3
major substructure conformations exist for p38 (blue, green and yellow clusters) and also
many outlier substructures (cyan and orange clusters). Further inspection of substructures
in the green cluster (e.g., PDB:3HEC) reveals they share the DFG-out conformation and
those in the blue cluster (e.g., PDB:3DT1) reveals that they correspond to DFG-in con-
formations. Finally, inspection of substructures from the yellow cluster (e.g., PDB:3IW7)
reveals a 3rd conformation that is unlike both the DFG-in and DFG-out conformations
as shown in Fig. 3.8(e). The high-level trends among the p38 substructures revealed the
distinct conformations of the DFG motif and identified a 3rd distinct type of conformation.
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(a)
(b)
(c)
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(e)
Figure 3.8 : FASST Live interactive data visualization In order to gain a deeper under-
standing into the clustering computed by FASST Live the color (a) and size (b) applied to
each feature vector can be modified. The location of feature vectors for specific substruc-
tures can be highlighted by hovering (d) or checking the PDB ID in the sorted list (c). The
visualization is implemented using a motion chart from the Google Chart Tools API. One
substructure from each of the major clusters is shown in (e). The green feature vectors
in the chart correspond to DFG-out conformations while the blue correspond to DFG-ing
conformations. The yellow feature vectors correspond to conformations that are neither
DFG-in nor DFG-out as demonstrated in (e).
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Figure 3.9 : Procedure for aligned substructure selection from MSA. The horizontal bars
denote aligned sequences within the MSA. The vertical bars denote columns within the MSA
that correspond to the selected substructure residue positions. The gaps in the vertical bars
represent missing residues within sequences X and Y. Substructures for sequences X and Y
are excluded because both lack one or more residues at the selected comparison positions
within the alignment.
3.11.2 Pfam-based MSA pipeline
Using a multiple sequence alignment (MSA) from the curated Pfam [30] protein family
database, corresponding substructures can be selected for all proteins in the MSA. The only
additional information needed from the user in order to run the Pfam alignment pipeline
(versus the single-sequence pipeline) is the Pfam ID for the protein family of interest.
In order to identify a substructure for sequence B given a reference substructure for
sequence A, MSA columns for the residues specified for sequence A are identified then used
to identifying the corresponding residue positions for sequence B. For example, as shown
in 3.9, nine protein sequences of an MSA are shown as horizontal bars and four residue
positions are highlighted as green vertical bars.
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An MSA alignment, like that illustrated in Fig. 3.9, provides a means of mapping residue
positions among proteins. In the case of our previous p38 example, the reference substruc-
ture used corresponding residue numbers 71, 75, 168, and 169 of PDB structure PDB:3HEC.
In the MSA illustration above, the 4 residues of our reference substructure are denoted by
green vertical bars and numbered 1 through 4. However, not every protein sequence in the
MSA will have a corresponding residue to the reference substructure, as illustrated by gaps
in the green vertical bars. These gapped sequences are excluded from the substructures
generated (sequences labeled X and Y in Fig. 3.9). All other protein sequences in the MSA
will be included in the comparison set generated.
3.11.3 User-defined alignment pipeline
Finally, the user can submit a fully defined set of aligned substructures using the custom
pipeline option, allowing the user to use any alignment method available to them as input
to FASST Live. Such an alignment may be computed by other algorithms for structure
(e.g., CE [49], SMAP [62], LabelHash [2]) or sequence alignment (e.g., MUSCLE [55] or
CLUSTALW [54]).
The only constraint imposed is that all substructures have an identical numbers of
residues specified. This constraint is due to the fact that the desired residue-residue cor-
respondence (between substructures) is derived from the order of residue numbers. The
required format for user-defined queries is comma-separated values (CSV) with the follow-
ing order:
pdbid, chainid, r0, r1, r2, ..., rk
For example, the following comparison set definition specifies 6 different protein sub-
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structures, each with 5 residues:
2gb8, A, 48,47,51,180,178
2jti, A, 48,47,51,180,178
3fm6, A, 43,42,46,174,172
3fmu, A, 43,42,46,174,172
2wd4, A, 38,37,41,168,166
1jdr, A, 48,47,51,180,178
In summary, the available analysis pipelines and interactive visualization provided by
FASST Live provides a web-based service for quickly computing substructure clusterings
with The FASST Framework without requiring the user to write code or install any addi-
tional software.
3.12 Conclusion
The FASST Framework provides the first general toolkit for constructing custom analysis
pipelines for large-scale, local structure analysis. Importantly, the methods describe allow
for the full incorporation of all available structure data without need for sequence redun-
dancy filtering and pruning. As demonstrated in Sec. 3.11.1, even the analysis of structure
data for a single protein sequence can identify unexpected structural trends, such as a 3rd
heavily populated conformation of the DFG motif, that would not be possible to identify
with only a single representative structure.
The substructure clusterings identified by FASST have been demonstrated both here and
previously [1] to be capable of identifying biologically meaningful structure trends among
both proteins sharing a common fold and proteins sharing only local structural similarity at
a handful of binding site residue positions.
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The dissemination of the general analysis framework introduced here as well as the
availability of the interactive FASST Live analysis platform will facilitate the incorpora-
tion of high-level local structure analysis among the growing protein structure databases.
Finally, the modularity and open source nature of The FASST Framework will allow for fur-
ther community-driven development and customization for application to a wider variety
of biological applications.
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Chapter 4
A Supervised Learning Approach:
CCORPS
4.1 Motivation
In addition to the increasingly large number of available protein structures, a wide spectrum
of large, well-curated annotation databases now exist [63, 64, 25, 30, 65, 66, 67, 68, 69,
70, 71, 72]. By mapping the sequence- and structure-specific annotations within these
databases to large structure datasets, a greater understanding of the source of structure
variation can be identified as demonstrated in previous work [1].
The FASST Framework approach discussed in the previous chapter provides a critical
foundation for constructing redundancy-aware unsupervised learning methods capable of
identifying high-level trends among the structural features of large protein datasets. By
the unsupervised nature of The FASST Framework, the method does not take into account
any additional biological knowledge beyond the sequence and structure of the proteins ana-
lyzed. This approach is particularly useful when performing an unbiased analysis of struc-
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Figure 4.1 : CCORPS overview.
ture variation for the purposes of identifying unique structure conformations or structure
outliers as discussed in Ch. 3.
However, in cases where annotations are available for the proteins being analyzed, a
new formulation of the structure analysis problem can be made. The FASST Framework
required knowledge of the specific substructure residue positions to analyze, but identifying
the residue positions responsible for structure variation that correlate with a particular set of
annotation labels a priori is highly non-trivial. The Combinatorial Clustering Of Residue
Position Subsets (CCORPS) method, introduced in this chapter, addresses this problem by
analyzing all possible residue position subsets in order to identify the structure features that
correlate with a given set of annotation labels. The CCORPS method then uses the identified
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structure features to predict the annotation labels of other structures lacking annotation, as
detailed in the following sections.
4.2 Problem statement
The supervised learning problem that CCORPS addresses can be stated as follows:
Find the structural features among the set of proteins that are correlated with
a particular set of annotation labels.
To implement this analysis, CCORPS provides the following interface:
• Input: aligned set of protein substructures
• Input: set of annotation labels
• Output: set of predicted annotation labels
For example, the per-substructure annotation labels may be derived from a wide range
of sources [63, 64, 25, 30, 65, 66, 67, 68, 69, 70, 71, 72]. In particular, the applications of
CCORPS presented in Ch. 5 and 6 incorporate EC class annotations and inhibitor binding
affinity annotations, respectively.
Furthermore, the annotation labels provided to CCORPS do not have to be available for
all substructures in the input dataset. Because CCORPS is semi-supervised (see Sec. 4.5),
annotation labels can be provided for only the subset of substructures where they are avail-
able. If, for example, n substructures are provided as input to CCORPS along with m anno-
tation labels (one or zero labels per substructure), where m< n, then the output of CCORPS
is the (n m) annotation label predictions for substructures lacking annotation.
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In order to assess prediction performance of CCORPS, cross-fold validation experiments
(Sec. 4.7) were performed, as discussed in Sec. 5.5 and Sec. 6.5. During cross-fold vali-
dation, a subset of the known annotation labels are masked, CCORPS is trained using the
remaining unmasked labels and finally CCORPS makes predictions for the masked labels.
This process is repeated for each of the validation folds as detailed in Sec. 4.7.
The aligned substructures can be derived using any of the approaches suggested in
Sec. 3.2 or Sec. 3.5.
4.3 Related work
In addition to the predicted annotation labels that CCORPS provides, the predictive struc-
tural features identified by CCORPS in computing the annotation label predictions are inter-
esting and useful in and of themselves. In some instances, the predictive structure features
identified by CCORPS may be related to Specificity Determining residue Positions (SDPs).
Existing structure-based supervised learning approaches such as the FEATURE frame-
work [73] have been demonstrated for the learning of structural features representative of
many types of functional sites (e.g., enzymatic, ion-binding). Supervised learning meth-
ods such as FEATURE have proven capable of identifying structural indicators of specific
functional sites by comparing the physicochemical properties of local micro-environments
within enzymes [74, 73, 75]. FEATURE demonstrates the ability of structure-based learning
approaches to identify structural trends within large structure datasets.
Incorporating structure data provides an additional dimension to the residue substitu-
tion pattern data that exists within MSAs. In addition to the chemical similarity that can be
compared across residues within an aligned sequence position, the structural conformation
and local 3D environment of each position can also be compared. Furthermore, structure
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data provides knowledge of residue neighbors in 3D that may be distant sequentially. How-
ever, appropriately compensating for structure overrepresentation while being able to take
advantage of the additional information provide by alternative structure conformations is
a major obstacle. Overcoming the problematic structural overrepresentation of some pro-
tein sequences within an alignment while still incorporating all available structure data is a
challenged specifically addressed by CCORPS.
4.4 Method overview
As input, CCORPS takes an aligned set of protein structures and a corresponding set of anno-
tation labels (one label per structure). Then, CCORPS compares the structural and chemical
similarity of subsets of the aligned positions across the alignment. Structural and chem-
ical features common to structures having the same annotation label, while distinct from
structures with differing annotation label, are detected as specificity-determining substruc-
ture instances. Finally, CCORPS predicts the annotation labels for structures with unknown
annotation label and ranks the specificity-determining power of the alignment positions
analyzed. For each specificity determining structural feature that is identified, as shown in
Section 4.5, the positions responsible for the specificity are tallied. The alignment positions
are finally ranked by their frequency of appearance in specificity-determining structural
features as detailed in Section 4.8.
4.4.1 Computing residue position subset clusterings
In order to identify locally similar features among sub-groups of protein structures, all k-
sized combinations of the r residue positions (i.e.,
 r
k
 
combinations) are generated. For
example, given r = 20 and k = 3, all
 20
3
 
3-position subsets (1140 subsets) are generated.
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Then, each of these position subsets are examined one-by-one. Continuing the example,
given the position subset (7,13,14), the protein structures are compared by examining the
pairwise similarity of only positions 7, 13, and 14 in isolation (i.e., disregarding the other
17 positions).
The steps outlined in Sections 3.7, 3.8, and 3.9 are repeated for each possible 3-position
subset in order to compare all possible local structural features across all proteins. Struc-
tural variation in most subsets is not expected to be informative, either because no signif-
icant variation is present, or because spurious patterns can occur due to chance. However,
functionally relevant structural variation can be detected with many different subsets and
therefore distinguished from random patterns, as will be shown below.
4.5 Selecting Highly Predictive Clusters (HPCs)
A cluster that is dominated by one annotation label can be used to predict the label for
other structures in that cluster whose annotation is unknown. We therefore call such clus-
ters Highly Predictive Clusters (HPCs). Identification of HPCs is performed by selecting a
minimum threshold for the label purity of clusters, and then selecting all clusters with equal
or greater label purity than this minimum as HPCs; we used the strictest purity threshold
possible (1.0 or 100% purity) in this work (see Fig. 4.2). Purity is calculated for a multiset
of labels, L, as purity= IL(mode(L))/|L| where IL is the multiplicity function of a label
within the multiset L and mode(L) is the most frequent label within L.
An important consideration when evaluating the purity of clusters for HPC selection
is the structural redundancy of the dataset. Overrepresented protein sequences will tend
to form clusters due to being alternative structures of the same or highly similar protein
sequences. A cluster of proteins made up of only a single or few highly similar sequences
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Figure 4.2 : Illustration of cluster evaluation procedure. The star and diamond symbols
represent structures with known labels and the question marks represent structures with an
unknown label. Clusters (a) and (b) will both be selected as HPCs for their respective labels
(star and diamond, respectively) because they are each pure in a single label (unknown
labels are disregarded). Cluster (c) will not be selected as an HPC because it has low purity.
is likely to exhibit label consensus by chance alone.
In order to eliminate label bias in clusters due to overrepresentation, a sequence non-
redundant version of cluster purity was implemented. Protein sequences were clustered for
all structures at the 100% sequence identity level for determining non-redundant groups in
this case. To adjust purity for structural overrepresentation, NR-purity is calculated as NR-
purity= ILnr(mode(Lnr)) where Lnr is one label from each NR 100 sequence identity cluster
that exists within L.
Additionally, the purity of a set of labels must address the presence of proteins with
unknown label in a cluster, which will occur because of the semi-supervised nature of
CCORPS. In this work, proteins with unknown labels have no effect on the purity calculated
for a set of labels. Therefore, we refer to the customized purity calculation used here as
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semi-supervised, non-redundant purity or SS-NR-purity.
Finally, purity alone does not account for the distinctness of the proteins in the cluster
relative to the remainder of the dataset. For example, an HPC for label l1 that partially
overlaps a second HPC for label l2 is less likely to be informative than a l1 cluster greatly
separated from the remainder of the dataset. The “degree of separation” or “distinctness” of
a cluster was quantified by calculating the cluster silhouette score [76]. The mean silhouette
score for a cluster was then used as a further selection criteria for identifying HPCs by
removing potential HPCs with negative average silhouette scores (malformed clusters).
4.5.1 Tallying votes for label predictions
Each time a protein falls within an HPC, that protein receives a single vote in favor of the
majority label associated with the HPC. Because a protein can be a member of at most
one cluster per k-position subset, the maximum number of votes any protein can receive is
equal to the number of possible k-position subsets. For any given k-position subset, it is
possible that all clusters are HPCs or that no clusters are HPCs depending on how the labels
are distributed among the clusters. It is also possible that a protein may never fall within
any HPC and therefore would receive zero votes for any label; such proteins are excluded
from further analysis after the voting step. In the experiments described in Ch. 5 and 6
this case rarely occurred. After tallying the label votes across all k-position subsets, the
label predicted for a given structure is then determined by selecting a decision boundary as
described next.
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4.6 Learning a decision boundary
Given a set of label votes that have been determined for an unlabeled structure, the thresh-
old(s) used to decide which of the two or more label classes to assign to the structure
requires the definition of a decision boundary procedure. For example, given a set of anno-
tation labels containing the label classes {true,false}, a simple decision rule may be that
given a structure with > 1 true vote, predict the true label for that structure. However,
determining a single threshold for deciding the number of label votes required to classify a
structure into one of several classes is difficult to generalize. Two approaches to selecting a
label prediction given the label votes for unlabeled structures are described below. The two
approaches were used in the applications of CCORPS in Ch. 5 and 6, respectively. While the
two approaches below were both proven effective for the applications demonstrated in this
thesis, a variety of supervised learning approaches could instead be applied to determine
the decision boundary (e.g., k-nearest neighbors, decision trees).
Majority vote
One simple alternative to selecting a static threshold for the number of votes required to
classify into a particular label class is to simple select the class that has the most votes,
regardless of the number of votes cast for other classes, individually or combined. (i.e., the
predicted label is the mode of the label votes). For example, given a structure with the label
votes {85 true, 1032 false}, a majority vote procedure would predict the false label for
the structure. In Ch. 5, this straightforward approach to predicting labels is illustrated to be
successful for selecting among k EC class labels.
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Support Vector Machine-based (SVM) decision boundary
However, the majority vote approach described above decays in predictive performance
when the label class distribution among the input substructures is highly non-uniform. For
example, if most proteins in the dataset are of label false and only a small fraction have
label true, then many HPCfalse clusters will be identified by chance alone because the
false label dominates the dataset. Simple majority voting will result in large numbers of
false negative predictions due to the abundancy of the false label.
Because CCORPS is a supervised approach, the labels for the training structures are
known and can be used to empirically estimate a vote count decision boundary. For ex-
ample, given structure X with known label, the number of times that X appeared in a
HPCfalse and HPCtrue across all k-position subsets can be calculated using the same ap-
proach as for unlabeled structures. The structure X is then represented by an |l|-dimensional
vote vector, where each of the l dimensions corresponds to the number of votes X received
for label li, 1  i  l. Application of this procedure to all labeled structures in the dataset
provides an empirical basis for calculating a decision boundary in the vote space given the
vote distribution for labeled structures. For example, the blue and red points shown in the
scatter plot of Fig. 4.3 denote the vote vectors for training set substructures with known
true and false labels, respectively.
Given the vote vectors calculated for all labeled training set substructures in the dataset,
it is then possible to then train any number of classifiers in order to determine a decision
boundary. To compute a decision boundary in the vote space for classifying unlabeled pro-
teins, SVM s were selected. First, an SVM (linear kernel) is trained using the vote vectors
of labeled training set substructures. For example, the decision boundary determined by
training an SVM on vote vectors is shown in Fig. 4.3 as the bold, black line. Next, for an
unlabeled substructure with a given vote vector, the label for the substructure can be pre-
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dicted by determining which side of the SVM decision hyperplane the unlabeled structure
falls within. As illustrated in Fig. 4.3, test vote vectors falling within the blue region will
be predicted as having the true label and those falling within the red region, the false
label.
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Figure 4.3 : Decision boundary for label vote vectors computed by SVM. In the above
scatter plot, each point corresponds to the number of true/false votes accumulated by
each substructure across all clusterings. Combining the above label vote vectors with the
known labels for substructures to train an SVM (using linear kernel) results in the decision
boundary shown as the bold black line. The red and blue regions (right and left sides of
the boundary, respectively) denote the values for which the predicted label will be false
and true, respectively. Blue points indicate substructures known to have the true label
while red points denote the false label. In the case of Roscovitine above, wide separation
between the two classes exists.
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4.7 Cross-fold validation
To assess the utility of HPCs for identifying substructure positions indicative of functional
specialization, a cross-fold validation can be performed as follows. First, the input sub-
structures are divided into 95% sequence identity groups (NR95-clusters), and each of these
NR95-clusters will be one fold. This procedure ensures no protein in a test set shares>95%
sequence identity with any protein in the training set for any given fold of the evaluation.
Because of the non-uniform distribution of structures across the NR95-clusters, the num-
ber of structures in the test set varies with each fold. In each fold, structures that were
part of the test set are marked with label unknown, and are disregarded when calculating
the SS-NR-purity of clusters during the HPC selection step, just as the structures with truly
unknown label.
Finally, standard k-fold cross validation was performed with each of the NR95-clusters
each being one fold (i.e., k = |NR95-clusters |). Given the NR95-clusters-based fold parti-
tioning above, the training set is used to identify HPCs and then tally label votes for each
structure in the test set of a fold. For a given test structure, the predicted label is compared
to the actual label and the result is tallied in a m⇥m confusion matrix, where m is the
number of unique labels.
4.8 Ranking of specificity determining positions
Each identified HPC represents a k-position subset of the alignment for which some subset
of the proteins within the family are structurally distinct from the remainder of the fam-
ily and all share a common annotation label; see Fig. 5.2 for examples of HPCs. Each
alignment position is ranked by the number of times that position belonged to a k-position
subset containing one or more HPCs; note that
 r
k
 
k-position subsets of r residue alignment
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positions exist. Tallying the number of HPC appearances for each position across all
 r
k
 
clusterings results in a per-position HPC tally. See Section 5.7 for additional details on the
ranking of SDPs for Pfam binding site positions.
4.9 Conclusion
The CCORPS method introduced here is completely automated and can be applied to a va-
riety of binding site analysis problems. The generality of the approach means that it can
be used for any kind of annotation label. The approach is also agnostic with respect to
the method used for alignment in similar fashion to The FASST Framework. In the fol-
lowing chapters, the application of CCORPS to the prediction of different sets of annotation
labels, such as enzymatic function specialization and kinase inhibitor binding affinity, will
be demonstrated.
To validate the predictive ability of the structural features identified by CCORPS an
extensive dataset of 48 families was automatically constructed using the Pfam database [77]
as a source of well-curated protein alignments. These benchmarking results are discussed in
Ch. 5. For the benchmarking experiments in Ch. 5, the annotation labels analyzed are per-
structure Enzyme Commission (EC) number classifications. Cross-validation is performed
in order to evaluate the predictive power of CCORPS and the utility of the distinguishing
structural features identified.
Beyond the benchmark Pfam+EC dataset presented here, CCORPS provides a general
framework for automatically learning structural features that distinguish proteins having
different annotation labels. A major advantage of the work presented is the generality of
CCORPS to detect structurally distinguishing features for a wide variety of applications
beyond enzymatic function specialization. No assumptions regarding the nature of the
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annotation labels nor of the alignment type are made at any point by CCORPS. That is, a
phylogenetic relationship is neither assumed nor required for input protein alignments. This
allows the incorporation of purely structure-based alignments, such as those available in
databases like HOMSTRAD [78] or even local structure alignments such as those identified
by motif/template search algorithms (e.g., SOIPPA, [62] and LabelHash, [2]). Other sources
of annotation labels, including Gene Ontology (GO, [63]) terms, binding affinity for a given
molecule and ligation state can be incorporated as-is with CCORPS without modification to
the method.
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Chapter 5
Predicting Enzymatic Classifications for
Protein Domains
5.1 Motivation
Large-scale analysis of the structural variation of protein enzymatic sites has become in-
creasingly important in identifying the role of specific structural features responsible for
functional diversification [26]. However, the inherent difficult of combining all of the
available structure data for a given protein sequence in order to consider all of the possible
binding site conformations present among structures with non-cognate ligands, transition
state analogs and also the apo, unbound state has proven difficult [33, 68].
Recent work [3, 79] has demonstrated that enzyme superfamilies tend to share a com-
mon catalytic core that is then embellished by the insertion of additional secondary struc-
ture elements and specificity loop substitutions that give rise to functional diversification.
Comparing the binding site specific structural variation present among these families of
homologous proteins has been shown to identify distant structural relationships that are
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sequence-based approaches fail to recognize [16].
In this chapter, the ability of CCORPS to successfully identify structural features that are
predictive of enzymatic specialization in families of homologous proteins is demonstrated
on a large protein family benchmark dataset for multiple levels of enzyme functional clas-
sification specificity.
After introducing the Pfam binding site dataset automatically constructed to benchmark
CCORPS, we will introduce three distinct results of the method. First, we will discuss the
accuracy of CCORPS in predicting EC classifications in a large-scale, cross-fold validation
experiment. Second, we will demonstrate that HPCs are capable of distinguishing structures
with differing EC classifications and that multiple HPCs can exist for a given EC class.
We conclude this section with a discussion of the identification of specificity determining
positions from HPCs.
The overall classification accuracy of CCORPS (Table 5.1) when applied to the Pfam+EC
dataset demonstrates the ability of CCORPS to identify structural features that distinguish
functionally different protein homologs.
5.2 Related work
A variety of approaches for identifying SDPs have been successfully demonstrated before.
Methods such as GroupSim [80], Xdet [81], MCdet [81] and ET [82] identify column posi-
tions within multiple sequence alignments (MSAs) that distinguish functional sub-families.
See [80] for a review of sequence-based approaches for SDP identification.
The recent FLORA [33] method uses a structure-based alignment approach called CATHE-
DRAL [48] to identify positions within domains that are structurally conserved among pro-
teins sharing a common function. However, to the best of our knowledge, no method is
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currently able to incorporate and examine all structure data available for a given homolo-
gous protein domain when identifying SDPs.
5.3 Dataset
All 12,273 protein families from the Pfam 25.0 release (April 2011) were considered for
inclusion in the dataset. Only protein families that met the following criteria were selected
for inclusion:   200 domain structures;   10 unique sequences,   2 distinct EC classes;
for the subset of sequences with known EC class,   2 sequences from each of   2 EC
classes, all having 50% sequence identity. Our dataset consists of the 48 protein families
that meet or exceed these criteria. The criteria were chosen so that there would be enough
structural and sequence diversity to make the prediction of EC classifications sufficiently
challenging.
5.3.1 Automated binding site definition
All alignments used in this work were derived from Pfam MSAs [77]. A Pfam MSA pro-
vides an alignment of homologous protein domains. For each aligned domain in an MSA,
the UniProt [83] ID is retrieved from the Pfam alignment and all PDB [17] structures cor-
responding to the given UniProt ID are mapped to the domain sequence. The Pfam MSA
alignment column positions define the mapping of residue positions across all structures
for a protein family. Examples of the binding site definitions automatically generated for
our dataset are shown in Fig. 5.1.
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(a) (b)
(c) (d)
Figure 5.1 : Binding site positions for some of the protein families analyzed by
CCORPS. A representative structure is shown for each family. The automatically selected
binding site residues are shown in white, while the ligand is shown in red. (a) ECH, (b)
COesterase, (c) Epimerase, and (d) Alpha-amylase.
5.3.2 Selecting binding site positions
For each aligned structure that contains one or more non-protein molecules (distinguished
by HETATM records) with   30 atoms, the largest available molecule was identified and
assumed to be a ligand. For each ligated structure, all residues having at least one atom
within 5A˚ of one or more ligand atoms were selected as potential binding site residues.
These binding site residues were then mapped to columns within the Pfam MSA. A count
is kept for the number of times each MSA column was mapped to a residue in a ligated
structure. After tabulating MSA column mapping counts across all ligated structures, only
MSA columns that were mapped to binding site residues in   5 instances were retained.
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5.3.3 Identifying a dense sub-alignment
Next, it is necessary to remove gaps from the input alignment so that all pairwise com-
parisons of binding site positions, as outlined in Section 3.7, are consistent. When gaps
appear in the aligned binding site column positions, either the entire column position must
be eliminated from further analysis or all protein structures having a gap at the alignment
position must be eliminated. This “densification” procedure of removing either a gapped
row (protein structure) or gapped column (alignment site position) is repeated until only
a fully “dense” (non-gapped) sub-matrix remains. In the resulting dense sub-matrix, all
remaining protein structures have a residue at all remaining alignment positions.
Finding the largest dense sub-matrix in the alignment as outlined above is equivalent
to finding a maximal edge biclique in a bipartite graph; a biclique is a complete bipartite
graph, where all possible edges exist between two bipartite sets of vertices. Given a graph
G = (V1+V2,E), alignment positions are vertices in V1 and protein structures are vertices
in V2. Each non-gapped position for a protein vi 2V1 at a position v j 2V2 in the alignment
is the edge E = v1v2. Identifying the maximal biclique in such a bipartite graph has been
shown to be NP-complete [84].
The heuristic densification approach implemented to identify dense sub-matrices of
alignments is as follows. (1) Given n structures aligned (with gaps) at m positions, convert
the alignment to an n⇥m binary matrix M such that M[i][ j] = 0 if structure i was gapped
in the alignment at position j and M[i][ j] = 1 otherwise. (2) Consider each row M[i] to
be a binary vector representing structure i. (3) Compute the complete-linkage hierarchical
clustering [85] of the binary vectors using the Hamming distance metric [86]. (4) Each node
of the resulting hierarchical clustering represents one potential sub-matrix. Calculate the
dense size of the sub-matrix by removing all rows or columns containing one or more zeros
from the sub-matrix and taking the sum of the remaining values. (5) Select the sub-matrix
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with maximal dense size. Note that the maximal dense sub-matrix selected in step (5) is not
guaranteed to be the optimal sub-matrix because every possible sub-matrix of the original
matrix does not exist as a node in the hierarchical clustering. The rows (protein structures)
and columns (alignment positions) for the selected dense sub-matrix are used to prune the
raw alignment positions and structures in order to provide a fully dense “sub-alignment” as
input to CCORPS.
Techniques used for finding dense sub-matrices within real-valued gene expression data
such as “biclustering” are potential alternatives to the heuristic approach used here (see
[87] for a review of biclustering approaches). However, the binding site position subset of
an alignment is often quite dense, making the sparseness assumptions of gene expression
biclustering methods unessential for the current Pfam alignment dataset.
5.3.4 Generating EC class annotation labels
For each protein structure in a family, several different annotation labels are generated
based upon the 4 tiers of EC classification. For example, a given structure with an EC
classification of the form A.B.C.D can be labeled for each tier of the EC as A.B.C.D,
A.B.C.⇤, A.B.⇤.⇤, or A.⇤.⇤.⇤. The 4-tiered label (A.B.C.D) provides a more precise
functional label than the 1-tiered version (A.⇤.⇤.⇤). The objective is to predict all 4 EC
labels for structures with unknown EC classification.
5.4 Problem definition
Given the protein family dataset described in Sec. 5.3, the predictive ability of CCORPS for
the identification of structural features specific to functional divergence among homologous
enzyme active sites was assessed. The aligned substructures generated for each Pfam fam-
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ily were independently provided as input to CCORPS along with the EC annotation labels
for each tier.
For each Pfam family, and each EC annotation label tier, individually, the aligned sub-
structures and annotation labels were provided as input to CCORPS and the cross-fold val-
idation procedure described in Sec. 4.7 was performed. That is, 42 (# families) ⇥ 4 (# EC
labelings) independent CCORPS cross-fold validations were performed.
Table 5.1 : Accuracy of predicted EC classifications for
Pfam protein families in cross-fold validation. Predictions
are made at all 4 tiers of the EC hierarchy.
Family statistics EC prediction accuracy (%)
Pfam ID #EC #Struct. Size⇤ 1-tier 2-tier 3-tier 4-tier
4HBT 5 37 28 100 95 95 10
AAA 4 57 14 30 26 26 26
ADH N 10 62 9 100 99 99 68
Aldedh 15 66 58 100 90 90 71
Alpha-amylase 16 220 26 89 89 89 71
Amino oxidase 7 51 33 100 12 12 6
Aminotran 1 2 15 148 32 96 95 95 39
Asp 11 54 75 100 100 100 14
COesterase 6 152 62 100 100 100 78
Cu-oxidase 7 95 11 100 88 49 49
DHFR 1 5 155 81 94 94 94 92
ECH 10 38 43 81 79 79 36
Epimerase 9 62 71 95 95 95 88
Ferritin 4 79 15 90 90 2 2
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Table 5.1 : Accuracy of predicted EC classifications for
Pfam protein families in cross-fold validation. Predictions
are made at all 4 tiers of the EC hierarchy.
Family statistics EC prediction accuracy (%)
Pfam ID #EC #Struct. Size⇤ 1-tier 2-tier 3-tier 4-tier
GST C 5 209 5 91 91 91 91
GST N 4 134 18 98 98 98 98
Glyco hydro 18 3 112 16 100 100 98 98
Gp dh C 4 47 11 100 100 100 88
Hexapep 13 76 13 90 75 75 48
Lactamase B 9 119 4 98 44 40 40
Ldh 1 C 4 112 3 100 100 100 58
Ldh 1 N 4 64 43 100 100 100 86
Lys 8 548 22 100 100 100 96
NUDIX 9 33 41 90 88 85 24
PALP 18 113 9 72 52 52 44
PDEase I 5 98 28 100 100 100 82
Peptidase C1 11 100 54 99 99 99 16
Peptidase C14 6 19 44 100 100 100 45
Peptidase M10 12 131 64 100 100 99 30
Peptidase S9 7 100 12 100 99 97 94
Pkinase 11 145 69 100 100 57 52
Pkinase Tyr 5 142 66 100 100 66 52
Proteasome 3 20 64 100 100 46 46
Proteasome A N 3 21 7 100 100 47 47
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Table 5.1 : Accuracy of predicted EC classifications for
Pfam protein families in cross-fold validation. Predictions
are made at all 4 tiers of the EC hierarchy.
Family statistics EC prediction accuracy (%)
Pfam ID #EC #Struct. Size⇤ 1-tier 2-tier 3-tier 4-tier
Pyr redox 21 145 14 100 65 65 57
Pyr redox 2 11 49 76 100 59 59 10
Pyr redox dim 12 94 7 100 56 56 38
RVP 9 418 35 99 99 97 93
Ribonuclease 6 158 14 100 100 91 52
Rieske 5 63 33 100 96 96 74
TPP enzyme C 11 59 21 83 83 56 48
TPP enzyme N 14 78 17 76 81 52 42
Thioredoxin 12 171 3 44 0 0 0
Thymidylat synt 5 106 45 92 92 92 86
adh short 21 137 65 100 72 72 35
efhand 14 308 17 15 15 1 0
p450 7 67 43 100 100 18 16
peroxidase 3 45 63 100 100 100 100
Mean 92 84 74 53
Standard Deviation 18 25 30 30
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5.5 Prediction performance
The protein family dataset that we have constructed in the manner described above covers
a wide range of families with very different levels of functional diversification and binding
site sizes as shown in Table 5.1. The mean number of unique EC classes across families
in the dataset was 8.3, with some families having as few as 3 different EC classes and as
many as 21. An even wider variance is seen for the number of structures available per
family, ranging from as few as 11 to as many as 548 with a mean of 108 for the dataset.
Finally, the number of binding site positions examined ranged from the minimum of 3 to
as many as 81 (mean of 33), covering a large range in binding site sizes.
The performance of CCORPS was evaluated by applying the cross-validation procedure
outlined in Section 4.7 to each of the protein families in the Pfam alignment dataset. For
each protein family, the ability of CCORPS to predict enzymatic function annotation labels
in the form of EC class numbers was quantified. The prediction accuracy of CCORPS for
predicting EC classification at each of the 4 tiers of EC specificity is show in Table 5.1.
Due to the hierarchical nature of the EC classification system, the number of unique
4-tier EC classes (most specific annotation labels) for a family is necessarily greater than
or equal to the number of unique 1-tier EC classes (least specific annotation labels). As can
be noted by examining the dataset mean prediction accuracy from 1-tier to 4-tier, accuracy
decreases with increasing EC classification annotation label specificity, as should be ex-
pected. The prediction accuracy at the least specific 1-tier EC classification was 92±18%,
while the accuracy dropped to 53± 30% for the most specific 4-tier. With these numbers
one needs to consider the very general automated procedure used to specify the input (e.g.,
the way binding site residues were chosen).
A major challenge when attempting to predict the 4-tier (most specific) EC annotation
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labels derives from the non-uniformity in structure coverage across the EC labels within
a protein family. What could be considered “outlier” EC classes with only a single corre-
sponding protein sequence within a protein family, were common throughout the dataset.
Given the stringent cross validation procedure used in this work, it is actually impossible to
correctly predict the annotation label for single-protein EC classes. This is due to the fact
that when the structures for the single-protein EC class fall within the test set during one
fold of the cross validation, no structures will exist in the training set that share the same
EC class label by definition of the NR-clusters. We chose to be conservative and not correct
for this self-penalizing aspect of our performance benchmarking. The reason for this is that
it reflects the realistic case of predicting enzymatic function for homologous proteins with
unknown function that may be novel relative to the training dataset.
5.6 Highly predictive clusters
The basis for the predictive ability of CCORPS is the detection of HPCs as outlined in Sec-
tion 4.5. The set of clusters identified by CCORPS for one of the 2600 3-position subsets for
the a-amylase family is shown in Fig. 5.2. Note that
 26
3
 
= 2600, where 26 is the number
of binding site positions available for the a-amylase protein family as listed in Table 5.1.
In the subplots of Fig. 5.2, the points shown each represent a feature vector (as calcu-
lated in Section 3.7), where each feature vector corresponds to a single protein substructure.
A tightly grouped cluster of feature vectors in the subplots of Fig. 5.2 reflects a set of sub-
structures sharing a high degree of structural and chemical similarity. Fig. 5.2(a) shows the
cluster membership automatically identified by CCORPS. Fig. 5.2(b) and (c) show the EC
annotation labels that map to each feature vector at the 3-tier and 4-tier levels, respectively.
In the last two plots the points are colored by EC tier level rather than by cluster.
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As can be seen in Fig. 5.2(b) and (c), several HPCs for different labels can exist simulta-
neously in a single clustering. Also, as shown in Fig. 5.2(b) for the 3-tier EC label 3.2.1,
multiple distinct HPCs for a single label can be identified. In other words, within EC label
3.2.1 several structural sub-groups can be detected. The existence of distinct HPCs for
a single label indicates that multiple structurally and chemically distinct sub-groups can
exist within a common annotation label. It is possible to identify such instances because
CCORPS makes no assumptions about the structural homogeneity of sub-families having
the same enzymatic function.
5.7 Identifying specificity determining positions
Because the residues which distinguish an EC class from the remainder of the family are not
necessarily the same for all EC classes within a protein family, SDPs are ranked separately
for each label.
Specificity determining binding site positions that distinguish a sub-family from other
homologous proteins with differing function are determined by constructing a relative rank-
ing of all binding site positions using the procedure outlined in Section 4.8. As shown
Figure 5.2 (preceding page): Substructure clustering for one 3-position subset of the
a-amylase binding site alignment. In each scatter plot above, the dimensionality-reduced
feature vectors computed by CCORPS are shown. Each point shown is one feature vector
and each feature vector represents one protein substructure. Tightly grouped points cor-
respond to binding site substructures with high structural and chemical similarity. Plots
(a), (b) and (c) above all show the same clustering with different sets of annotation labels
applied (labels are denoted by color): (a) cluster ID labeling; (b) 3-tier EC labeling; (c) 4-
tier EC labeling. Solid ellipses indicated clusters identified automatically as HPCs. Dashed
ellipses indicate subsets of non-HPC clusters that would have been considered HPCs if the
clustering step had distinguished each as a separate cluster.
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Figure 5.3 : Predicted binding site specificity determining positions for the a-Amylase
family. The a-Amylase binding site positions are shown in stick above with bound ligand
in yellow, high-ranking SDPs for EC 2.4.1.* (229 and 227) are colored red, high-ranking
SDP s for EC 5.4.99.* (341 and 340) are colored blue. For the 3 bar charts, the residue
number for each alignment position considered is shown along the x-axis (residue number-
ing is according to PDB:3EDF); the number of instances where the position corresponded
to a clustering containing one or more HPCs is shown on the y-axis. The positions are
sorted along the x-axis in order of specificity determining power. Note that no prominent
alignment positions were identified for EC 3.2.1.* in this case.
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in Fig. 5.3 for the tier-3 EC annotation labels and the a-amylase protein family, a sep-
arate ranking is constructed for each EC class. The position rankings for EC 2.4.1.*
and 5.4.99.* reveal that positions 229 and 227 for 2.4.1.* and positions 340 and 341
for 5.4.99.* appear much more frequently in HPCs for their respective labels than the
remaining binding site positions. In contrast, all positions occur with similar frequency
within HPCs for label 3.2.1.*, which seems to indicate that the binding sites of proteins
in EC 3.2.1.* as a whole differ quite significantly from the binding sites of all other
proteins in the family.
5.8 Conclusion
As demonstrated in this chapter, CCORPS is able to identify structural features that are
predictive of enzymatic function specialization within families of homologous proteins.
Additionally, the predictive structural features can be used to evaluate the contribution of
individual binding site residue positions towards determining functional specificity. Many
of the component steps of CCORPS can be further refined in order to improve the predictive
performance of CCORPS. For example, the initial binding site position selection method-
ology (Section 5.3.1) has a drastic impact on the performance of CCORPS, because if a
true SDP is not included among the positions provided to CCORPS, it will of course not
be identified. While determining a binding site region for a single ligated structure is very
well-defined by simply selecting all residues within a distance cutoff of the ligand, defining
a true “consensus binding site” across a large, heterogeneous set of structures, in general,
is not well-defined due to the lack of a complete one-to-one mapping among all secondary
structure components for the set of structures.
While the SDP ranking presented here can identify prominent positions in the case of
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some EC classes, as illustrated with the a-amylases in Fig. 5.3, determining a statistical
cutoff for distinguishing SDP s from non-SDP s based upon the rankings is challenging.
This will require the development of a statistical model that properly incorporates the prior
probability of HPCs based upon the distribution of annotation labels within a protein family
as well as the likelihood of HPCs occurring by chance alone.
CCORPS provides a local structure-based approach to identifying potential SDP s and
predictive structural features for enzymatic function specialization. The redundancy-aware
methodology implemented by CCORPS allows for all available structure data to be incorpo-
rated without prior filtering or redundancy removal and systematically accounts for struc-
tural overrepresentation within each method step. The large protein family dataset analyzed
here demonstrates the success of the method across a wide variety of different binding site
and family sizes, with many families having a very large number of unique EC class anno-
tation labels to predict. As will be further demonstrated in the following chapter, CCORPS
can be applied to make even more fine-grained, molecule specific binding predictions for
families exhibiting large amounts of structural conservation within the binding site region
analyzed.
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Chapter 6
Predicting Binding Affinity for the Human
Kinome
6.1 Motivation
The protein kinases constitute the largest enzyme family encoded by the human genome,
with currently 518 known instances, making up 1.7% of all human genes [9, 4]. Because
these protein kinases are intimately involved in cellular communication and regulation net-
works, the loss of normal kinase regulation has been implicated in a wide variety of patho-
logical conditions. The number of disease states found to be associated with kinase dys-
regulation has motivated the development of kinase-specific inhibitor compounds. Because
of the number of kinase-associated conditions, the protein kinases have come to constitute
20-30% of the drug development programs at many companies [9].
Due to the large number of existing protein kinase domains and the high degree of
(ATP) binding site similarity among them, designing highly selective inhibitors has proven
difficult. For example, type I kinase inhibitors that only target the ATP site have typically
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been found to have low selectivity across the kinome [10]. To increase inhibitor selectivity,
type II inhibitors bind both the ATP site and the immediately adjacent allosteric site. By
also binding to the allosteric site, type II inhibitors are able to make additional highly
specific interactions, thereby allowing them to be more selective [10]. However, identifying
highly specific structural features that can be uniquely targeted by inhibitors requires the
comparison of local structural similarity across kinase binding sites.
Many of the effective inhibitor selectivity strategies involve exploiting the differences in
the size of the ATP binding site and targeting residue variability at a few key positions [10,
11]. These structure-based comparison approaches have proven more useful than sequence-
only measures of overall kinase similarity in evaluating the potential selectivity profile of
inhibitors [11]. For example, the size of the gatekeeper residue directly moderates the
availability of the hydrophobic pocket. Inhibitors having larger functional groups that bind
the hydrophobic pocket may be able to select for the roughly 20% of protein kinases that
have a relatively small gatekeeper residue (e.g., Gly, Val, Ala or Thr), because kinases
having a larger gatekeeper residue (e.g., Phe) do not have a large enough hydrophobic
pocket to accommodate the inhibitor [11]. However, in order to select for an even more
specific subset of the human kinome, it has proven necessary to take advantage of multiple
structural features of the kinase binding site (both ATP and allosteric sites) simultaneously.
Because of the importance of identifying trends among multiple structural features for a
variety of different kinases, a comparative analysis of structure-affinity relationships within
the kinome is presented here. By incorporating all available structural data for each kinase
binding site, such as the variety of binding conformations that exist for with multiple ligated
compounds, CCORPS is demonstrated to be capable of predicting the binding ability of
kinase inhibitors across the human kinome.
76
STE
TKLTK
CMGC
AGC
CAMK
CK1
Figure 6.1 : Phylogenetic tree of the human kinome. The following seven ma-
jor families make up the major branches of the kinome as shown above: containing
PKA, PKG, PKC (AGC); Calcium/calmodulin-dependent protein kinase (CAMK); Ca-
sein kinase 1 (CK1); CMGC Containing CDK, MAPK, GSK3, CLK families; STE Ho-
mologs of yeast Sterile 7, Sterile 11, Sterile 20 kinases; TK Tyrosine kinase; TKL Ty-
rosine kinaselike [4]. The kinase dendrogram was adapted and is reproduced with per-
mission from Science (http://www.sciencemag.org) and Cell Signaling Technology, Inc.
(http://www.cellsignal.com)
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6.2 Related work
The release of kinome-wide affinity screening datasets, such as that of Karaman et al.
2008 [6] and Fabian et al. 2005 [88], provides a novel opportunity to identify structural
trends as they relate to binding affinity across kinases. Recent work [89, 90] has illustrated
that local structural similarity exists among phylogenetically diverse groups of kinases and
have highlighted the importance of large-scale, multiple-structure analysis of structure-
affinity relationships among the kinases.
Recent work by Jackson et al. 2009 demonstrated a structural clustering approach to
predicting kinase inhibitor binding affinities. Their geometric hashing approach to whole-
site comparison of the ATP binding pocket was demonstrated to be effective at identifying
possible instances of inhibitor cross-reactivity and further emphasized the importance of
taking into account subtle conformational changes in the binding site.
Instead of whole-site comparison, recent work by Huang et al. 2010 [11] utilized a
knowledge-based approach to constructing a minimal binding site “fingerprint” that cap-
tures only a pre-specified set of well-studied structurally selective features, such as the size
and hydrogen-bonding ability of the gatekeeper residue.
However, even given the successes of existing approaches for predicting kinase affinity,
several outstanding problems remain. The whole-site-based affinity prediction method of
Jackson et al. 2009 relies upon the selection of a reference structure, known to bind a par-
ticular inhibitor, against which the similarity of all other sites are ranked. As noted in their
prediction results for imatinib affinity prediction, the performance varied greatly depending
on the particular structure selected as a reference. The approach used by CCORPS, how-
ever, provides an automated way to incorporate the similarity of an unannotated structure
to all annotated structures without the need to manually select a reference. Because of the
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variability in binding site conformation (e.g., DFGmotif), poor reference structure selection
can have drastic effects upon the identified structural similarity.
The approach implemented by CCORPS here allows not only the effective prediction
of binding affinity across a variety of small molecule inhibitors, but as a by-product of
the learning process, also identifies many instances of structurally similar features among
phylogenetically diverse kinases, as will be demonstrated below.
6.3 Dataset
The kinome structural dataset was constructed from all structures annotated as belonging to
PFAM:PKINASE and PFAM:PKINASE TYR (all ePK domains, aPK s excluded) in release 25
of Pfam. After the binding site residue positions to analyze were selected (see Sec. 6.3.2)
and proteins having one or more gaps at those positions were excluded, a total of 1958
structures remained. These 1958 structures correspond to 208 unique kinase proteins. The
distribution of sequences and structures across the seven major kinome families is shown
in the table below:
AGC CAMK CK1 CMGC Other STE TK TKL Unclassified
# Structures 171 231 20 500 114 55 445 58 364
# Sequences 19 34 6 33 18 17 47 9 75
# Annotated 6 13 2 16 5 11 35 6 43
As will be detailed in Sec. 6.3.3, 1281 of the 1958 structures (65.4%) were part of the ki-
nome inhibitor affinity dataset of Karaman et al. 2008 and therefore have known annotation
labels for each of the 38 inhibitors tested.
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Figure 6.2 : Structure-based binding site alignment via MATT. In order to identify a
mapping between residues in the TK and non-TK Pfam alignments, MATT [5] was used to
compute a structural alignment of the kinase domains of p38 structure PDB:3HEC (white)
and LCK structure PDB:2PL0 (black), both with bound imatinib inhibitor (red). The Ca
RMSD of the above binding site alignment region (27 residue positions) was 1.169 A˚and
the RMSD of the imatinib inhibitors is 1.736 A˚; the imatinib molecule coordinates were
ignored during computation of the alignment.
6.3.1 Eukaryotic protein kinase alignment
In the case of the ePKs, both the non-TKs (PFAM:PKINASE) and TKs (PFAM:PKINASE TYR)
were combined into a single, comprehensive structural dataset in order to provide struc-
tural coverage for the full kinase family tree. However, determining an appropriate residue
position correspondence between the TK and non-TK family alignments requires an addi-
tional alignment step, in order to relate columns from the TK alignment to columns of the
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non-TK alignment. Several approaches for obtaining a consistent and high-quality align-
ment between the TKs and non-TKs were considered, such as profile-profile alignment and
structure-based alignment.
To provide a structure-based solution to determining a high-quality residue position
correspondence between the TKs and non-TK s, MATT [5] (version 1.00) was selected due
to its ability to focus the alignment on regions of structural similarity (e.g., the ATP binding
site) while disregarding regions with low structural similarity (e.g., C-terminal region). The
kinase domain of non-TKs and TKs was then aligned using MATT by structural superposi-
tion of a pair of representative structures (PDB:3HEC and PDB:2PL0, respectively), that had
both been co-crystallized with the same ATP binding site inhibitor (imatinib). The align-
ment RMSD of the common core region (220 residues) identified by MATT was 2.156 A˚;
the RMSD of the bound imatinib molecules was 1.736 A˚. The MATT alignment is shown for
the binding site residue positions analyzed here in Fig. 6.2; the Ca RMSD of the 27 binding
site residues shown is 1.169 A˚. The aligned computed by MATT is shown in Listing 2.
6.3.2 Binding site residue position selection
All residues having one or more atoms within 5A˚ of one or more imatinib atoms from
the imatinib-bound structures PDB:2PL0 or PDB:3HEC were selected as candidate binding
site positions. Candidate positions were eliminated if they corresponded to highly gapped
columns in either the PFAM:PKINASE or PFAM:PKINASE TYR MSAs. After filtering the 27
binding site residue positions shown in Fig. 6.2: 30, 38, 51, 52, 53, 71, 74, 75,
78, 83, 84, 104, 105, 106, 107, 108, 109, 111, 146, 147, 148, 149, 157,
166, 167, 168, 169 (residue numbering according to PDB:3HEC).
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Core Residues: 220
Core RMSD: 2.156
3HEC:A R--------------------PTFYRQELNKTIWEVPERYQNLSPVGSGAYG-----SVC 39 (A)
2PL0:A -GSHMQTQKPQKPWWEDEWEVP--------------RETLKLVERLG-----AGQFGEVW 260 (B)
3HEC:A AAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 97 (A)
2PL0:A MGYYNG-HTKVAVKSLKQ--G---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----- 309 (B)
3HEC:A EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP 153 (A)
2PL0:A --EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA 367 (B)
3HEC:A SNLAVNEDCELKILDFGLARHTDDEMTGYVA-------------------TRWYRAPEIM 194 (A)
2PL0:A ANILVSDTLSCKIADF---------------GLARLIEDNEYTAREGAKFPIKWTAPEAI 412 (B)
3HEC:A LNWMHYNQTVDIWSVGCIMAELLTG-RTLF--PGTDHIDQLKLI--LRLVGTPGAELLKK 249 (A)
2PL0:A NYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYR----------- 458 (B)
3HEC:A ISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308 (A)
2PL0:A ----------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV-LE 495 (B)
3HEC:A AQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPP------------- 352 (A)
2PL0:A D-------------------------------------------FFTATEGQYQPQP 509 (B)
Listing 2: Structure-based alignment computed by MATT between TK and non-TK struc-
tures PDB:2PL0 and PDB:3HEC, respectively.
6.3.3 Kinase inhibitor affinity annotation labels
The binding affinity (Kd’s) for 38 small molecule kinase inhibitor compounds was deter-
mined for a set of 317 kinases using an in vitro competition binding assay by Karaman et
al. 2008 [6]. The 38 inhibitors tested include staurosporine, 1 lipid kinase inhibitor, 15
serine-threonine kinase inhibitors and 21 tyrosine kinase inhibitors. Affinity values were
mapped from the Karaman et al. 2008 dataset to kinome structural dataset by mapping
the NCBI RefSeq IDs provided by Karaman et al. 2008 to the UniProtKBIDs [83] of the
proteins in the structural dataset. 137 of the 208 protein sequences in the structural dataset
mapped to the affinity dataset published by Karaman et al. 2008.
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Figure 6.3 : Kinase affinity dataset. Kinome affinity maps for the 38 inhibitor dataset
of Karaman et al. 2008. Adapted by permission from Macmillan Publishers Ltd: Nature
Biotechnology [6], copyright 2008. The kinase dendrogram was adapted and is reproduced
with permission from Science (http://www.sciencemag.org) and Cell Signaling Technol-
ogy, Inc. (http://www.cellsignal.com).
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In order to simplify the problem of correlating structural features with binding affinities,
the binding affinity (Kd) values were binned into 2 classes (true/false) by thresholding
the affinity values at 10µM(i.e., <10µM! true;  10µM! false). This cutoff between
the two label classes was used consistently across all inhibitors.
6.4 Problem definition
Given the aligned kinase binding site substructures selected in Sec. 6.3.2 and the inhibitor
affinity annotation labels as generated in Sec. 6.3.3, the ability of CCORPS to predict the
affinity for each inhibitor was assessed using the cross-fold validation approach described
in Sec. 4.7. For each of the 38 inhibitor annotation label sets, an independent evaluation
of CCORPS was performed. No information was shared between the evaluations in order
to validate the predictive ability of CCORPS to identify structural features predictive of the
binding ability of each inhibitor independently.
6.5 Prediction performance
For each of the 38 inhibitors included in the affinity dataset, CCORPS was used to predict
the set of kinases able to bind to that inhibitor. The performance of CCORPS was assessed
for each inhibitor, independently, by computing the Receiver Operator Characteristic (ROC)
curve [91] for the set of predictions, which evaluates the sensitivity (# true positives / (#
true positives + # false negatives)) at each specificity (# true negatives / (# true negatives + #
false positives)) value. The ROC curves for the predictor constructed by CCORPS are shown
in Fig. 6.4 for each inhibitor and the Area Under Curve (AUC) [91] for each ROC curve is
listed in Table 6.1. Additionally, the Precision-Recall (PR) curve [91] for each inhibitor can
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be found in Fig. 6.5. The PR curve plots the precision (# true positives / (# true positives +
# false positives)) versus the recall (equivalent to sensitivity).
In order to make a direct comparison of the performance of CCORPS to the work of
Jackson et al. 2009, another performance measure, the enrichment factor, was also com-
puted per inhibitor tested. The enrichment factor of the top 5% most highly ranked true
affinity predictions (for a given inhibitor) can be calculated as follows:
E5% =
Atop 5%/Ntop 5%
Atotal/Ntotal
(6.1)
where Atop 5% is the number of structures with known affinity for a given inhibitor (# ac-
tives) in the top 5% of most confident predictions as ranked by CCORPS, Ntop 5% is the
total number of structures in the top 5%, Atotal is the total number of active structures in
the dataset and Ntotal is total number of structures in the dataset. The enrichment factor at
5% (E5%) for each inhibitor is shown in Table 6.1 and where available, the corresponding
E5% values from Jackson et al. 2009 are listed alongside. It should be noted that the E5%
values are not directly comparable between CCORPS and Jackson et al. 2009 as listed in Ta-
ble 6.1, due to the fact that the maximum possible enrichment (Emax) for a given inhibitor
is dataset-dependent, and the dataset presented in this work is larger both in number of
structures compared and the number of per-inhibitor affinity annotations.
As shown in Table. 6.1, CCORPS achieves high predictive performance across the 38 in-
hibitors tested. As quantified by E5%, CCORPS achieved perfect or near-perfect predictive
ability for 12 of the 38 inhibitors (AST-487, BMS-387032, CHIR-258, CHIR-265, EKB-
569, GW-786034, MLN-8054, roscovitine, SB-202190, sorafenib, sunitinib and ZD-6474),
while only exhibiting overall poor performance for one inhibitor, GW-2580. CCORPS was
unable to identify predictive structural features consistent among kinases capable of bind-
85
ing GW-2580. However, features consistent among kinases unable to bind GW-2580 were
identified, resulting in CCORPS (incorrectly) predicting the false label for all kinases with
respect to GW-2580 binding. To summarize, CCORPS is demonstrated to consistently meet
or exceed the predictive ability of the method by Jackson et al. 2009 as also shown in
Table 6.1.
6.6 Highly predictive clusters
In the process of identifying structural features within the kinome that are predictive of
affinity for a particular inhibitor, CCORPS computes the substructure clustering for all pos-
sible 3-position subsets of the original 27-position binding site definition (see Sec. 6.3.2).
One of the 2925 substructure clusterings computed for the kinome is shown in Fig. 6.6(b).
Each point within Fig. 6.6(b) represents the feature vector, as computed by CCORPS, for
a single 3-position substructure; that is, each of the 1958 substructures within the kinase
structure dataset is shown. As demonstrated in Fig. 6.6(c), where one randomly selected
representative substructure is shown for each of the 21 clusters identified by CCORPS, both
the geometry and residue types vary significantly among the kinases.
Because of the structural and chemical variance exhibited by kinases at the 3-position
substructure shown in Fig. 6.6(c), several Highly Predictive Clusters (HPCs) can be identi-
fied in Fig. 6.6(b). These HPCs are clusters consisting of substructures all sharing the same
affinity annotation label (either all true or all false). As discussed in Sec. 4.5.1, affinity
annotation labels are predicted by tallying the number of times an unannotated structure is
co-clustered into an HPC for each possible label (true and false here) and then applying
the SVM-based decision boundary, as was detailed in Sec. 4.6. Note that the final prediction
made by CCORPS for any particular structure is based upon the HPC s identified across all
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Figure 6.4 : Per drug Receiver Operator Characteristic (ROC) curves. The x- and y-
axis plot (1-specificity) and sensitivity, respectively, both ranging from 0 to 1. The Area
Under Curve (AUCROC) as well as the E5% per drug can be found in in Table 6.1. As shown
above, CCORPS is able to construct a near-perfect classifier for several drugs, such as PI-
103, SB-431542. The classifiers constructed for some inhibitors, such as flavopiridol, are
able to achieve high precision, but only at low sensitivities (recalls), as further illustrated
by the PR curves in Fig. 6.5.
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Figure 6.5 : Per drug Precision-Recall (PR) curves. The x- and y-axis plot the recall and
precision, respectively, both ranging from 0 to 1. The Area Under Curve (AUCPR) per drug
can be found in Table 6.1. As shown above, CCORPS is demonstrated to have very high
precision across a wide range of inhibitors when tested for targets spanning the kinome.
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CCORPS Jackson et al. 2009
Inhibitor AUCROC AUCPR E5% Emax E5% Emax
ABT-869 0.84 0.49 5.14 (8.43)
AMG-706 0.89 0.73 5.97 (6.71)
AST-487 0.87 0.91 1.71 (1.71)
AZD-1152HQPA 0.84 0.45 3.71 (6.78)
BIRB-796 0.77 0.53 1.99 (3.27) 3.65 (3.98)
BMS-387032 0.90 0.80 3.52 (3.69)
CHIR-258 0.89 0.86 4.05 (4.05)
CHIR-265 0.97 0.85 7.01 (7.24)
CI-1033 0.82 0.64 3.57 (4.48)
CP-690550 0.94 0.22 8.21 (32.85)
CP-724714 0.97 0.85 16.31 (23.72)
Dasatinib 0.81 0.58 1.31 (2.89)
EKB-569 0.89 0.75 4.57 (4.64)
Erlotinib 0.88 0.65 4.64 (5.50) 6.89 (9.19)
Flavopiridol 0.65 0.65 2.90 (3.09)
GW-2580 0.54 0.00 0.00 (256.20)
GW-786034 0.86 0.70 5.20 (5.45)
Gefitinib 0.70 0.32 3.63 (9.28)
Imatinib 0.89 0.48 6.49 (11.86) 2.99,5.98 (11.95)
JNJ-7706621 0.89 0.82 1.13 (2.00)
LY-333531 0.90 0.53 2.53 (7.04)
Lapatinib 0.97 0.85 16.31 (23.72) 0.00 (19.92)
MLN-518 0.87 0.24 3.73 (21.71)
MLN-8054 0.91 0.72 6.85 (6.85)
PI-103 1.00 0.97 16.01 (16.01)
PKC-412 0.66 0.58 1.62 (2.20)
PTK-787 0.95 0.23 7.57 (34.62)
Roscovitine 0.93 0.79 4.67 (4.82) 2.81 (2.81)
SB-202190 0.97 0.92 4.15 (4.21)
SB-203580 0.87 0.71 3.11 (3.69) 5.43 (5.43)
SB-431542 1.00 0.98 20.02 (49.27)
SU-14813 0.85 0.70 2.60 (3.09)
Sorafenib 0.89 0.75 3.82 (4.08)
Staurosporine 0.89 0.97 1.00 (1.15)
Sunitinib 0.83 0.72 2.48 (2.52)
VX-680 0.83 0.68 1.66 (2.95)
VX-745 0.83 0.54 5.05 (6.34)
ZD-6474 0.95 0.88 4.53 (4.53)
Table 6.1 : Affinity prediction performance of CCORPS for the kinase inhibitors. For
each of the 38 inhibitors in the affinity dataset of Karaman et al. 2008, the prediction
performance of CCORPS is shown above for the performance metrics discussed in Sec. 6.5.
The performance of the Jackson et al. 2009 method is shown alongside that of CCORPS
for the subset of inhibitors tested by both methods. Note that for imatinib, two E5% values
are provided by Jackson et al. 2009 because each value is derived by selecting a different
reference structure as discussed in Sec. 6.2.
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of the 2925 substructure clusterings, not just the single clustering illustrated in Fig. 6.6.
Several informative observations regarding kinase structural diversity and its associa-
tion to inhibitor binding affinity can be made by further examination of the substructure
clustering shown in Fig. 6.6(b). Immediately upon examination of the substructure cluster-
ing it can be noted that multiple distinct clusters of kinases exist. This observation alone
indicates that the 3-position substructure that resulted in this clustering is highly diverse
among kinase binding sites. Conversely, the presence of a single large cluster would indi-
cate that the 3-position substructure was structurally conserved, exhibiting little variance
across the kinome; indeed instances of clusterings with a single dominating cluster were
also observed for some 3-position subsets. As demonstrated in Fig. 6.6(c), where one ran-
domly selected representative substructure is shown for each of the 21 clusters identified by
CCORPS, both the geometry and residue types vary significantly for this 3-position subset.
By incorporating the affinity annotation labels for a particular inhibitor, further ob-
servations can be made about the association between the 3-position substructure shown
in Fig. 6.6(a) and the kinases capable of binding that inhibitor. For example, mapping
the affinity annotation labels for the inhibitor flavopiridol onto the substructure clustering
(Fig. 6.6(d)) reveals that some of the clusters consist purely of only a single annotation label
while others are a mixture of labels. In Fig. 6.6(d), kinases capable of binding flavopiri-
dol are colored red (true label), kinases incapable of binding flavopiridol are colored gray
(false label) and kinases lacking affinity annotation are colored white (undefined label).
As illustrated in Fig. 4.2, HPCs are clusters that consist of a single annotation label. As
shown in Fig. 6.6(d), multiple clusters of purely true labels exist and are considered to be
HPCs by CCORPS.
The existence of true-only clusters indicates that the 3-positions shown in Fig. 6.6(a)
are a distinguishing structural feature for identifying kinases that bind flavopiridol. More
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interestingly, however, is the fact that multiple, structurally distinct versions of the same 3-
position substructure exist for different kinases that all are capable of binding flavopiridol.
This result is significant because it indicates that different kinases have different structural
motifs that are associated with binding flavopiridol, as opposed to a single, shared structural
motif across all flavopiridol-binding kinases.
Furthermore, the existence of clusters containing only kinases incapable of binding
flavopiridol can also be observed in Fig. 6.6(d). These HPCs are also informative because
they identify particular structural versions of the 3-position substructure in Fig. 6.6(a) that
are all incapable of binding flavopiridol. Finally, clusters consisting of a mixture of kinases
that are both capable and incapable of binding flavopiridol can be identified in Fig. 6.6(d).
For kinases in these clusters, the 3-position substructure is not a distinguishing feature of
flavopiridol-binding ability.
Finally, while flavopiridol is discussed in detail here, the same analysis was computed
by CCORPS for each of the 38 different inhibitors within the affinity dataset. For each
of the inhibitors, the affinity labels can be mapped separately onto the same substructure
clustering as shown in Fig. 6.7. However, it should be noted that no information is shared
between the results for different inhibitors in this work; that is, each inhibitor is computed
in a fully separate CCORPS computation (the substructure clusterings do not vary, just the
annotation labels).
Examination of the affinity-annotated substructure clusterings shown in Fig. 6.7 reveals
that the set of clusters which are HPCs varies greatly depending on the inhibitor considered.
While the flavopiridol-annotated substructure clustering contains multiple HPCs for both
true and false labels, the correspondingly annotated clustering for other inhibitors, such
as VX-745, PI-103 and imatinib, contain only false HPCs. This result demonstrates that
the substructures that are informative of inhibitor binding are inherently inhibitor-specific.
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That is, a subset of binding site positions that are predictive for one inhibitor are not nec-
essarily predictive for another inhibitor.
6.7 Phylogenetically diverse HPCs
Numerous instances of cross-family affinity for both type I and II kinase inhibitors have
been identified, as is clearly illustrated by the kinome affinity maps created by Karaman
et al. 2008 (Fig. 6.3) using their kinome-wide affinity screening dataset. It is important to
identify structural features shared among phylogenetically diverse kinases that share affin-
ity for a particular inhibitor, because they provide a basis for reasoning about inhibitor
cross-reactivity. Furthermore, by identifying these shared structural features, it may be
possible to rationally reengineer the specificity of inhibitors by avoiding the targeting of
these features, since they are not unique to the intended kinase target. In order to identify
the number of instances of cross-family structural features that can be associated with spe-
cific inhibitor binding, the distribution of substructure clusters across all 3-position subsets
was analyzed.
Each individual cluster, across all 2925 clusterings and all 38 inhibitors, was evaluated
to calculate the SS-NR-purity of both affinity labels and family-level phylogenetic labels.
For example, a cluster containing 3 distinct kinase sequences with affinity labels {true,
false, true } and family labels {AGC, CAMK, TK } would have an affinity SS-NR-purity
of 0.66 and a phylogenetic SS-NR-purity of 0.33. By plotting the affinity and phylogenetic
SS-NR-purity scores of each cluster (separately for each inhibitor) as shown in Fig. 6.8, the
distribution of clusters across the spectrum of possible scores can be evaluated. As can be
seen in Fig. 6.8, many phylogenetically diverse clusters of 100% affinity purity labels exist.
This result indicates that shared structural features across family-level boundaries within
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Figure 6.6 : Highly predictive clusters. (a) Structure of lck (PDB:2PL0) with 3-position
substructure shown in blue stick representation (Thr-316, Tyr-318, Gly-322) and bound
imatinib molecule in red. (b) Substructure clustering computed by CCORPS when compar-
ing the 3-positions shown in (a) across the entire 1958 structure dataset. Each point in the
clustering represents a single 3-residue substructure. The red and black coloring of each
point indicates true and false affinity labels for flavopiridol, respectively, while white
indicates substructures lacking affinity annotations. (c) Aligned 3-residue substructure rep-
resentatives from each of the 21 clusters identified by CCORPS for the 3-position subset
shown in (a). The color of each substructure corresponds to its cluster assignment. (d) The
same substructure clustering shown in (b) but relabeled to indicate the cluster membership
of each substructure (21 clusters in total are shown). It should be noted that only one of the
2925 clusterings computed by CCORPS is shown above, with only one of the 38 inhibitor
affinity labelings shown.
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the kinome exist and can be correlated with shared binding affinity for particular inhibitors.
As further demonstrated by the corresponding distributions for all 38 inhibitors in Fig. 6.9,
such shared structural similarity is not rare.
In order to build intuition for interpreting the cluster distributions, the cluster distribu-
tion for VX-680 (Fig. 6.8) is first examined in more detail because it is representative of the
distribution for many of the other inhibitors. As listed in Table 6.2, 23,495 clusters were
identified by CCORPS that have  0.5 SS-NR-purity in the true label for VX-680 (hereafter
referred to as true-majority clusters). Only these true-majority clusters are plotted in the
cluster distribution shown in Fig. 6.8, meaning the minimum “affinity purity” displayed in
Fig. 6.8 is 0.5 by definition (because only 2 different affinity labels exist, true and false).
As can be seen in Fig. 6.8, the vast majority of clusters identified by CCORPS have
low affinity SS-NR-purity as well as low phylogenetic SS-NR-purity. This is to be ex-
pected because highly conserved portions of the kinase ATP binding site are known to ex-
ist. Structural features that consist of conserved residue positions will be common to many
kinases from different families due to the fact that these positions are so heavily conserved,
which explains the low phylogenetic SS-NR-purity of these clusters. Furthermore, these
conserved features are unlikely to be correlated with the affinity for a particular inhibitor
because most inhibitors have been engineered to not have broad cross-reactivity across the
kinome. However, staurosporine is known to have broad cross reactivity due to its interac-
tion with highly conserved binding site features; the cluster distribution corresponding to
staurosporine (Fig. 6.9) is markedly different from the other inhibitors with most clusters
having high affinity SS-NR-purity across a range of phylogenetic SS-NR-purity values.
Examination of the extremes of the VX-680 cluster distribution reveals further insights
into the frequency of structural similar features among kinases with different degrees of
sequence similarity. Clusters having a phylogenetic SS-NR-purity of 1.0 (i.e., all proteins
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belong to the same family) but having low affinity SS-NR-purity exist, and for VX-680 in
particular, 276 such clusters were identified by CCORPS. This observation is interesting be-
cause it illustrates that kinases sharing sequence similarity (relative to kinases outside the
family) have multiple common structural features that are not informative of the ability of
these kinases to bind VX-680. Because CCORPS only incorporates clusters with high affin-
ity SS-NR-purity (i.e., HPCs), these conserved structural features that are not indicative of
VX-680 binding are ignored by CCORPS when predicting affinity for unannotated kinases.
This observation can also be made for each of the other inhibitors as shown in Fig. 6.9.
Another interesting extreme of the VX-680 cluster distribution to examine is the exis-
tence of HPCs that are phylogenetically diverse. The HPCs selected by CCORPS correspond
to the right-most column of points in Fig. 6.8; these clusters all have an affinity SS-NR-
purity of 1.0 for VX-680 and therefore contain only structures with known VX-680 affin-
ity. As can be noted in Fig. 6.8, HPCs exist at a range of phylogenetic SS-NR-purity values.
CCORPS identified a total of 2707 HPCs for VX-680, and 1786 (66%) of these HPCs contain
proteins belonging to two or more distinct kinase families. This result demonstrates that
CCORPS is capable of identifying cross-family structural features that are associated with
VX-680 binding. Furthermore, this result is not unique to VX-680. As shown in Fig. 6.9
and tabulated in Table 6.2, cross-family structural features associated with inhibitor binding
were identified for all of the inhibitors tested with the exception of GW-2580, for which no
true-majority HPCs were identified.
Examination of the cluster distributions across each of the inhibitors reveals a wide
range of observations. While many inhibitors have a cluster distribution similar to that of
VX-680, for some inhibitors CCORPS identified relatively fewer true-majority clusters.
For example, only 133 clusters with affinity SS-NR-purity>0.5 were identified by CCORPS
for SB-431542 and all of these happen to be HPCs. However, even among this relatively
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low number of HPCs, 69 (52%) of the clusters contain kinases from two or more families.
As demonstrated by the corresponding distributions for all 38 inhibitors in Fig. 6.9, such
shared structural similarity is not rare.
6.8 Conclusion
The high degree of ATP binding site similarity shared across the protein kinases has made
them a difficult target for which to design highly selective inhibitors. However, by iden-
tifying the patterns of local structural similarity among binding sites at the kinome scale,
potential off-target interactions may be able to be identified at earlier stages of pharmaceu-
tical development and compensated for by further inhibitor modification.
As was demonstrated here, CCORPS is capable incorporating all of the available pro-
tein kinase structure data, so as to operate at the kinome scale, and then uses this data
to construct highly accurate predictors of kinase affinity for a variety of different small
molecule inhibitors. While CCORPS relies upon the aggregation of structural similarity
that coincides with affinity similarity to build predictors, the individual instances may be
informative in and of themselves. Further analysis of the vast number of structurally simi-
lar features shared among phylogenetically distant kinases may provide additional insights
into the structural mechanisms of inhibitor recognition occurring across the kinome. Struc-
tural features that are found to be unique to one or a small number of chosen kinases may
provide the starting point for designing highly specific inhibitor interactions and therefore
highly selective protein kinase inhibitors.
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Inhibitor # true-HPCs #  2 Families
ABT-869 345 249
AMG-706 274 202
AST-487 2415 1955
AZD-1152HQPA 506 374
BIRB-796 893 730
BMS-387032 728 447
CHIR-258 1577 800
CHIR-265 242 184
CI-1033 1247 704
CP-690550 11 5
CP-724714 115 89
Dasatinib 1848 1193
EKB-569 1133 684
Erlotinib 596 456
Flavopiridol 921 481
GW-2580 0 0
GW-786034 1443 809
Gefitinib 203 169
Imatinib 57 45
JNJ-7706621 4087 2761
LY-333531 634 314
Lapatinib 115 89
MLN-518 92 70
MLN-8054 435 301
PI-103 182 69
PKC-412 3419 2368
PTK-787 7 6
Roscovitine 593 335
SB-202190 644 513
SB-203580 738 546
SB-431542 133 69
SU-14813 4415 3116
Sorafenib 561 405
Staurosporine 17098 14802
Sunitinib 5525 4077
VX-680 2707 1786
VX-745 189 151
ZD-6474 1059 610
Table 6.2 : Phylogenetically diverse HPC statistics per inhibitor. For each inhibitor, the
total number of true-HPCs (column “# true-HPCs”) is shown. The subset of true-HPCs
that consist of proteins from two or more of the kinase families defined by Manning et
al. [4] (column “#  2 families”) are also shown. The multitude of true-HPCs that include
proteins from distinct families of the kinome can be noted by the relatively large percentage
(73% overall across all inhibitors) of HPCs that span families.
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Figure 6.7 : Affinity annotation labeling for all 38 inhibitors. The substructure clustering
computed for the same 3 positions examined in Fig. 6.6 is relabeled above for each of
the 38 inhibitors included in the dataset. In each cell above, red and black indicate the
true and false affinity labels, respectively, for each inhibitor, while white indicates a
lack of annotation. As can be noted by comparing the distribution of red points across the
different inhibitors, for most inhibitors, the kinase proteins capable of binding to them are
not distributed in a single cluster, indicating structurally diverse features exist among the
kinases selected by each inhibitor.
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Figure 6.8 : Distribution of phylogenetic and affinity SS-NR-purity cluster scores for
VX-680. Each point in the scatter plot above marks the SS-NR-purity for the drug affin-
ity true label on the x-axis and the phylogenetic label SS-NR-purity on the y-axis. For
example, a point above located at the coordinates (1.0, 0.2) denotes a cluster that is
100% pure in the true drug affinity label (for VX-680 in this case) but is only 20% pure
in the most common phylogenetic label present; that is, this cluster indicates one instance
of structural similarity among phylogenetically diverse proteins that is also coincides with
having affinity for VX-680. Conversely, a point at the coordinates (0.5, 1.0) indicates a
cluster that contains only structures from one phylogenetic (family-level) branch but con-
tains an equal proportion of true and false affinity labels; that is, a case where structurally
similar, closely related (phylogenetically) structures have different affinities for VX-680.
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Figure 6.9 : Distribution of phylogenetic and affinity SS-NR-purity cluster scores for all
drugs. As can be seen in the case of drugs such as imatinib and lapatinib, very few clusters
that have a majority of true labels were identified, yet clusters of phylogenetically diverse
structures all having true labels can be identified. Staurosporine exhibits a reflected dis-
tribution relative to the other drugs, because due the nature of its non-selectivity across the
kinome, instances of phylogenetically distant structures that exhibit Staurosporine affinity
are common. Refer to Fig. 6.8 for additional details.
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Chapter 7
Conclusion
This thesis introduces two fundamental approaches for learning structure-function relation-
ships among large protein structure datasets.
The FASST Framework demonstrates a highly modular unsupervised learning approach
to identifying the variability of local structural features among large numbers of structures
for the selection of unique structural conformations and the detection of outlier structures.
Additionally, the interactive FASST Live visualization and analysis tool provides a platform
for the broad dissemination of such techniques into the research community.
The supervised learning approach implemented by CCORPS provides an approach to
automatically identify the structural features of large families of proteins that give rise to
different sets of annotation labels, such as ligand binding affinity and functional diversifi-
cation. The ability of CCORPS to accurately predict the affinity of protein kinase inhibitors
across the human kinome for the 38 compound dataset was demonstrated. Furthermore, the
generality of the approach implemented by CCORPS was also demonstrated by predicting
the enzymatic function class of proteins from 48 different functionally diverse families.
Together, these approaches provide a principled mechanism for the incorporation of
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all available structural data. Instead of considering the abundance of alternative structures
for many proteins a hindrance that necessitates careful filtering and removal, the methods
presented here harness structural overrepresentation to provide an unbiased representation
of the true variety of protein structure datasets.
As the quantity of both protein structure data and protein functional annotations con-
tinue to grow, the learning methods introduced here will become increasingly necessary in
order to undertake comparative structural studies at the level of whole protein families.
Future work may take advantage of the additional structural data available from protein-
ligand co-crystal structures. For example, the kinase inhibitor experiments presented in this
thesis could be further enhanced by additionally considering the 3-dimensional conforma-
tion of the bound inhibitors and the specific interactions (e.g., hydrogen bonding) being
made to the kinase binding site residue positions. Furthermore, many kinase inhibitors
have common chemical groups and identifying the connection between shared inhibitor
chemical groups and shared inhibition of specific sets of kinases would further increase
our current understanding of kinase inhibition and may lead to the development of novel,
highly-selective kinase inhibitors.
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